Introduction to Environmental Risk Assessment and High-Throughput Screening 1 Fundamentals of Environmental Risk Assessment

J.P. Staveley, Exponent
Risk assessment has been defined as a process that evaluates the likelihood that adverse effects may occur or are occurring as the result of exposure to one or more stressors. Thus, the aspects of both exposure and effects are integral to understanding risk. The paradigm for conducting environmental (or ecological) risk assessment involves four components: problem formulation, exposure characterization, effects characterization, and risk characterization. Effects characterization describes relationships between the type and magnitude of the stressor (e.g., chemical) and the response of ecological receptors (i.e., organisms, populations, communities, ecosystems). Effects data have traditionally been derived from laboratory or field studies with representative aquatic or terrestrial species, although structure-activity relationship predictions are also used in the absence of such data. Importantly, the measures of effect that are of concern in ecological risk assessment are those that relate to population-relevant endpoints (typically survival, growth and reproduction) because the concern is generally for protecting populations, not individuals as is the case for human health risk assessment. The prospect of conducting whole organism testing to obtain data for these types of endpoints on the universe of chemicals, let alone mixtures, and considering a variety of species, is daunting. Thus, the opportunity afforded by high throughput screening (HTS) tests to support effects characterization for environmental risk assessment is attractive. The adverse outcome pathway (AOP) concept provides a useful construct for linking biological changes at the molecular level, cellular, or tissue level, such as may be observed in HTS tests, through processes at successively higher levels of biological organization to an observable adverse outcome, which is a biological change considered relevant for risk assessment. This information can be useful for identifying mode of action (MOA), and links can be made across chemicals with similar MOA and/or across species where the MOA is conserved. Potential uses of HTS data for environmental effects characterization include chemical prioritization, read-across from one species to others, use in intelligent testing strategies, and examining relative species sensitivity. However, there are numerous challenges in building confidence that HTS methods can ultimately be used to evaluate population-level impacts for ecological receptors.
A National Strategy to Modernize Safety Testing
N. Kleinstreuer, NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM)
During 2017, the federal interagency coordinating committee for validation of alternative methods (ICCVAM) coordinated the development of a strategic roadmap for incorporating new approaches into safety testing of chemicals and medical products in the United States. The roadmap was developed with participation from all sixteen ICCVAM member federal agencies and multiple interagency workgroups, with input from a broad range of stakeholder organizations. The roadmap describes a new framework for the safety testing of drugs and chemicals, which aims to provide more human-and ecologically-relevant toxicology data while reducing the use of animals. The successful development and implementation of these new approaches will require coordinated efforts that address three strategic goals: 1) Connecting end-users with developers of new approach methodologies; 2) Fostering the use of efficient, flexible, and robust practices to establish confidence in new methods; 3) Encouraging the adoption and use of new methods and approaches by federal agencies and regulated industries. The final roadmap document was published online in January 2018, and activities are underway to address the roadmap goals, and to develop and follow implementation plans for a variety of toxicological endpoints. Acceptance and utilization of HTS data and alternatives has already increased markedly in areas such as endocrine disruptor screening, topical hypersensitivity testing, and acute systemic toxicity prediction, both from an industry user perspective and in regulatory decision-making. Individual ICCVAM agencies and regulatory program offices have released detailed roadmaps addressing specific chemical sectors or legislative mandates (e.g. USEPA-TSCA and FDA), and the new Tox21 strategic plan establishes multiple cross-partner projects to develop, validate and deploy alternative test systems that are predictive of human toxicity and dose response. These efforts will be discussed in the context of national coordination across federal agencies and key stakeholders, and global harmonization with international partners.
Accelerating the Development and Use of High-Throughput Screening Data for Application to Regulatory Risk Assessments
R. Thomas, USEPA / Office of Research and Development / National Center for Computational Toxicology
The path for incorporating new approach methods and technologies into quantitative chemical risk assessment poses a diverse set of scientific challenges. Internal and external collaborative efforts are critical to support USEPA activities such as TSCA, as well as advancing chemical safety testing on an international level. The Agency has engaged in a series of national and international collaborative initiatives to pool expertise and this presentation will include overviews of some of these collaborations including: TOX21, a consortium of US federal agencies with NIH/NCATS, NIEHS/NTP and the FDA that is focused on developing and applying relevant HTS methods; Singapore's Agency for Science, Technology and Research (A*STAR) that is focused on developing in vitro models for predicting liver, kidney, and developmental toxicity; the ACPRA (Accelerating the Pace of Chemical Risk Assessment) project, an international effort to foster more rapid acceptance and use of highthroughput screening data in risk assessments; and the USEPA's efforts to implement the amended Toxic Substances Control Act, where USEPA is working with national stakeholders. Collectively, these efforts continue to accelerate the development, use, and application of high-throughput screening methods to better protect public health. This abstract does not necessarily reflect USEPA policy.
HTPS In Vitro Human Bell-based Toxicity Screening of Compounds and Water Samples
P.A. Behnisch, B. van der Burg, A. Brouwer, Biodetection Systems BV
Applying robotic human cell-based TA reporter gene assays for toxicity hazard identification of chemicals and complex mixtures in environmental matrixes (such as water) allows to analyse known and unknown toxic profiles. We will give an overview about standardisation efforts (e.g. OECD, ISO 19040) and outcomes of several EU projects (e.g. DEMEAU, ChemScreen, AquaNes) which used such human cell based TA reportergene assays to set up a broad screening system for cytotoxicity, genotoxicity, oxidative stressors, endocrine disruptors (EATS) and obesogens. In several EU countries such bioanalysis tools are now widely used in water quality assessment and first trigger values are proposed. Such effect-based diagnostic bioanalytical tools have many unique advantages, such as low cost, low detection limits, high throughput and quantitative results from complex mixtures of all kinds of matrixes. Characteristic bioanalytical profiles with particular groups of toxicity pathways will be presented from known and unknown compounds: e.g. AhR ligands, endocrine disrupting chemicals, aromatic amines or polyhalogenated compounds. Our bioassays have been automated using a compact liquid handling system. Chemicals are reported with EC10 values, while water samples are reported in Toxic Equivalents. Our results of a wide variety of compounds and complex cocktails in environmental samples revealed so far the importance of endocrine -(particularly the activation on estrogen, inhibition of androgen and inhibition of progesterone receptors) and activation on the aryl hydrocarbon receptor pathways of many known/ unknown substances and complex mixtures in environmental samples. The in vitro HTPS toxicity profiling of a wide variety of compounds and complex cocktails in environmental samples will be a step forward in the demonstration of the usefulness of quantitative effect-based diagnostic tools in water quality monitoring. A wide variety of all kinds of mixtures of waste streams of numerous industries ending up in water makes it necessary to use easy, fast, low-cost robotic HTPS tools to cover the high amount of new potentially compounds with unknown structure & toxicity and identity which may be missed by conventional chemical analysis.
Looking for Data in All the (Sometimes) Right Places, from Experts to Machines and the Databases in Between
S. Bell, Integrated Laboratory Systems, Inc
Data, especially "good" data, is the most coveted resource for any decision making effort and this holds true for high throughput chemical safety evaluations. But what defines good data and where can we find it? Does one really need to stalk PIs to get access to in vivo endpoints or develop a database containing all the knowledge of Google to get modeling data? This talk will cover points of consideration when defining criteria for "data quality" (spoiler-it's complicated) and provide examples of where to obtain data supporting construction of chemical safety analyses that can be used in environmental risk assessments. Case studies include: expert literature mining the old fashioned way, using robots to do your bidding, and the NICEATM Integrated Chemical Environment (ICE) as data resource for obtaining data relevant chemical safety data for use in risk assessments. Additional data resources and pitfalls to avoid in both defining decision criteria used in the search strategy as well as data integration will be highlighted along the way.
In Silico Approaches for Predicting Hazards from Chemical Structure and Existing Data
L. Burgoon, US Army Engineer Research and Development Center / Environmental Laboratory
In many real-world environmental risk management scenarios we face a situation where we have mixtures of chemicals going into the environment. But for many chemicals and mixtures we have very little information about the hazards they pose to threatened and endangered species and agriculturally relevant species including pollinators and food species, making this a food, environment, and national security issue. In this talk I will discuss our latest work on bridging the hazard assessment knowledge gap using in silico methods, including the use of Deep Learning Artificial Neural Networks, causal network theory and Adverse Outcome Pathways Bayesian Networks (AOPBNs). I will also discuss the challenges we face when applying these approaches to threatened and endangered species and agriculturally relevant species, and how we are trying to overcome them.
Challenges to the Use of Mechanistic and In Vitro Data in Environmental Risk Assessment -Emerging Solutions 7 Historical and Perceived Limitations to the Use of Mechanistic Data in Environmental Risk Assessment
V. Forbes, University of Minnesota / Ecology, Evolution and Behavior
Much of the information used to assess the ecological risks of chemicals is gathered from standardized tests conducted under controlled laboratory conditions that measure individual organism responses in a handful of species. There are various reasons for this -some historical and some pragmatic. Yet it is generally recognized that there is a wide gap between the toxicological responses of individuals of these few species and the kinds of entities that ecological risk assessment aims to protect (i.e., populations, communities, ecosystem processes and services). Exciting developments in HTS and in vitro technologies hold promise, but such endpoints are even further removed from ecological protection goals and so add uncertainties that need to be addressed. Whereas mechanistic studies of organismal and sub-organismal responses to chemicals can provide important insights into how chemicals disrupt different aspects of biological function, using such responses as proxies for likely ecological impacts is problematic. The use of mechanistic data to assess risk is limited by nonlinearities, contingencies, reliance on empirical correlations, and the dynamic nature of ecological systems. Quantitative, mechanistic models -informed by relevant data -are essential for overcoming these limitations, and progress is being made on this front.
Linking Mechanistic Data to Endpoints of Regulatory Concern Using the Adverse Outcome Pathway Framework
D.L. Villeneuve, USEPA / National Health and Environmental Effects Research Laboratory
Gene expression, enzyme activities, receptor binding, metabolite or hormone concentrations, altered morphology, behavior, etc. are widely used endpoints in both toxicological research and high throughput screening (HTS). However, to date these types of measurements are rarely, if ever, used as primary assessment endpoints in risk assessment. The disconnect between this kind of data and the endpoints and outcomes that we generally regulate on and manage has been recognized as a major barrier to the application of HTS data in environmental risk assessment. The adverse outcome pathway (AOP) framework was designed specifically to address that barrier. An AOP is a conceptual framework that captures and organizes information concerning the linkage between some direct molecular initiating event, through which a chemical interacts with a molecule in the body of an organism to perturb its biology, and a cascade of measureable biological changes that reflect progression toward and adverse outcome considered relevant to risk assessment and regulatory decision-making. Measureable "key events" along the AOP can serve as biomarkers of exposure and/or effect. "Key event relationships" define the biological basis of the linkage, the empirical support available in the extant literature, the quantitative understanding of how much change in a biomarker signals progression toward adversity, and the biological context (in terms of life-stage, sex, taxa, etc.) in which a particular outcome is likely to be relevant. Consequently, the AOP framework is expected to play an important role in facilitating more widespread use of HTS data and steps are being taken to more tightly couple AOP information to HTS data sets. Nonetheless, broader engagement of the scientific community in AOP development is needed to provide a robust interpretive framework for HTS application. The contents of this abstract neither constitute nor necessarily reflect USEPA policy.
Translating In Vitro Effect Concentrations to In Vivo Dose and Environmental Exposure Concentrations
N. Kramer, F.J. Taverne, R. Gehring, Utrecht University / Institute for Risk Assessment Sciences
The role of in vitro bioassays in toxicological risk assessment is changing from a hazard identification screening tool towards a hazard characterization tool replacing animal tests. In this new role, concentration-effect relationships that perturb a biological pathway in an in vitro cell assay is translated to human or animal toxicologically equivalent doses, a procedure referred to as quantitative in vitro-in vivo extrapolation (QIVIVE). QIVIVE models can range from simple linear regressions relating EC50 in cytotoxicity assays to acute LC50 in fish bioassays, to complex physiologically based kinetic (PBK) models relating key event perturbations by chemicals in an in vitro test battery representing an adverse outcome pathway (AOP) to steady state plasma concentrations after repeated oral exposure to drugs. Here, three examples of QIVIVE approaches are illustrated. The aim of the first example is to illustrate the need to consider freely dissolved and cell-associated concentrations in in vitro toxicity assays to accurately extrapolate to acute lethal concentrations of industrial chemicals in fish. The second example illustrates a tiered approach to PBK modeling to assess human equivalent doses after acute and chronic exposure to neuro-and nephrotoxicants. In the last example, the use of PBK modeling for species extrapolation of equivalent doses of veterinary antibiotics is explored.
Challenges in Extrapolating from Lab to Field and from Individuals to Populations and Ecosystems
V. Forbes, University of Minnesota / Ecology, Evolution and Behavior
Extrapolating toxicity test results from the laboratory to the field involves extrapolating across exposure scenarios (e.g., temporal and spatial variability in exposure, continuous vs. non-continuous exposure, different exposure pathways); accounting for ecological complexities that are not present in the lab (e.g., habitat heterogeneity, resource limitation, and presence of other stressors); and extrapolating from responses in test species to all of the species they are supposed to represent. Extrapolating from individual survival, growth and reproduction to population dynamics is complicated by differences in species life history; which individual-level response(s) is(are) affected; the status of the population (i.e., growing, shrinking or stable); and the strength and form of density-dependence. Extrapolating further to the ecosystem level requires an understanding of inter-species interactions; the relative importance of direct and indirect effects; and the relationship between species composition and ecosystem processes. Additional concerns include the potential for multi-generation effects as well as adaptation and the costs thereof, though these issues have been less well studied to date. Whereas modeling tools exist to overcome these challenges, more transparency and consistency are needed in model development, application and communication. While having the opportunity to hear from experts in the field as to how high-throughput (HTP) data and tools can be used to provide activity/ hazard and exposure information relevant for use in a broad range of risk assessment scenarios, being able to apply what is learned to real-world challenges will provide workshop participants the opportunity to gain some practical experience in the use of these types of data (and have some fun). Participants will be provided with three different story problems, and a budget, and will have the opportunity to "buy" the results of HTP tests from our genius bar vendors for use in addressing the questions posed in the scenarios. The first story problem is a field application, focusing on the use of in vitro bioassays to assess water quality in a catchment and to develop a cost-effective long-term monitoring program. The second scenario will provide participants with the opportunity to use HTP data to identify replacement flame-retardants that better meet the requirements for a "green" labeling initiative, based on their environmental fate and toxicity profiles. The final scenario centers on the use of HTP data in a weightof-evidence assessment of a pesticide to identify the potential mode of action. Time will be provided throughout the workshop to interact with the vendors, as well as other participants, in order to identify solutions to these real-world challenges. A session on the final day of the workshop will offer participants the opportunity to share the results of these practical exercises and discuss identified challenges and research needs. The U.S. Environmental Protection Agency (USEPA) ToxCast data pipeline (tcpl) has been applied to >1000 assay endpoints as first tier data processing of bioactivity data from high-throughput screening (HTS). The objective of using tcpl, and required database structure, is to organize data from many sources and formats to create a transferrable resource and shared vocabulary for HTS applications. First, tcpl and the structure of invitrodb will be reviewed with a discussion of data "levels," or formatted data for preparation and completion of curve-fitting. Curvefitting analysis (levels 4-6) generates concentration-response parameters, including the 50% activity concentration (AC50). Often the data available in level 5, including the AC50 or positive hitcall, may be useful in addressing toxicological questions. However, there are multiple sources of potential variability in these AC50s, resulting from biological variance, experimental error, or curve-fitting procedures. Ongoing work to implement a bootstrap resampling method, available as the toxboot R package, for generation of uncertainty information for AC50s from tcpl will be briefly discussed as a vision of what to expect in future data releases. Such uncertainty information may be useful in interpreting ToxCast data for various uses, e.g. supporting biological key event relationships or for use in preliminary screening level risk assessment. Briefly, toxboot uses smooth nonparametric bootstrap resampling to add random normally distributed noise to give a resampled set of concentration-response values. Useful outputs from toxboot may include hit percent, the probability of a positive hitcall given the collection of 1000 data resamples, and the AC50 median and confidence interval used to quantify AC50 variability. Application of toxboot to ToxCast data provides a robust estimation of curve-fit reproducibility and AC50 uncertainty. Finally, an example of ToxCast data in action will be briefly reviewed: the high-throughput H295R assay, which demonstrates a dataset analyzed with tcpl, as well as a custom analysis to generate fit-for-purpose endocrine bioactivity screening information. This abstract does not necessarily reflect USEPA policy.
Using the ToxCast and Tox21 Data
Development and Distribution of Test Method Documentation for ToxCast High-Throughout Testing Assays
S. Flood, ORAU at USEPA / National Center for Computational Toxicology; K. Houck, USEPA
Major concerns exist for the large number of environmental chemicals which lack toxicity data. The tens of thousands of commercial substances in need of screening for potential human health effects would cost millions of dollars and take several decades to test in traditional animal-based guideline studies, and these concerns have led many researchers to increasingly rely on alternative screening methods. High-throughput testing (HTT) methods have been developed to evaluate the hazard potential of diverse chemical libraries and are helpful in prioritizing the compounds of greatest concern for adverse effects. As part of a multiagency project to identify substances for prioritized testing, the USEPA 's National Center for Computational Toxicology (NCCT) ToxCast program has, to date, screened >3800 unique compounds for biological activity in some or all of over 800 assays. These efforts are designed to inform decision-makers of the bioactivity and/or toxicity of chemicals, but there remains a need to establish confidence in the applicability of these novel technologies to regulatory agencies. Here we describe the status of the NCCT's development of descriptive ToxCast assay documentation designed to implement OECD Guidance Document No. 211 recommendations for describing nonguideline in vitro test methods to diverse audiences. These annotations are designed to offer a clear and comprehensive depiction of all aspects of the ToxCast and Tox21 assays -from the development of novel methods, to the technological relevancy for examinating chemical-target interactions, through the interpretation of the >1600 different analytical endpoints. Alterations and additions to the OECD Guidance template were necessary to a limited extent to accommodate existing data infrastructure supporting the ToxCast program. Integrating detailed context-based textual information with structured ontology-based annotations into a publicly available database will facilitate the evaluation of these assays for regulatory applications. Our current work will provide critical feedback useful in future improvements to the OECD reporting template. This work is concurrent with efforts to deposit ToxCast data into other publicly accessible repositories (e.g., PubChem BioAssay and DB-ALM) and will help fulfill NCCT's commitment to increasing transparency and public accessibility to information produced by HTT studies conducted under the ToxCast program. This abstract does not reflect USEPA policy.
Understanding the Biology and Technology of ToxCast and Tox21 Assays
K. Houck, USEPA
The ToxCast and Tox21 high-throughput toxicity (HTT) testing methods have been developed to evaluate the hazard potential of diverse environmental, industrial and consumer product chemicals. The main goal is prioritizing the compounds of greatest concern for more detailed toxicological study. These methods consist of a broad suite of in vitro and model organism assays covering a wide range of molecular targets, pathways and biological processes. The screening platforms range from biochemical assays to complex primary cell systems to developing zebrafish embryos. Technological approaches of these assays are also highly varied with readouts consisting of fluorescence, luminescence, radioligands, imaging and analytical chemistry. This diversity of targets, formats and technologies have varied and important considerations for appropriate contextual interpretation of testing results. For example, a chemical with cytotoxic effects in a loss-of-signal cellular assay may appear to be positive; however, the activity may be a false positive with respect to the intended biological target. This session will cover the major assay sources and platforms for the ToxCast and Tox21 data including intended biological targets being measured and caveats to interpretation of screening results. This abstract does not reflect USEPA policy. Identification of chemicals with potential to impact thyroid hormone function is a priority of the USEPA 's Endocrine Disruptor Screening Program (EDSP). In vitro screening assays can be used to significantly reduce the number of chemicals that need to be considered for testing in higher-tiered test protocols by identifying chemicals that can affect critical key events in pathways necessary for normal thyroid hormone function, and more importantly, by identifying chemicals that are not likely to directly affect the thyroid-axis. Three molecular initiating events deemed of greatest priority were addressed first to develop, adapt, and implement assays to more rapidly assess the interaction of chemicals with these targets within the thyroid-axis. These included two assays covering activities integral to thyroid hormone production: a thyroperoxidase (TPO) inhibition assay and an iodide uptake inhibition assay. Deiodinase (DIO) enzyme activity assays were also developed to address chemical inhibition of hormone activation and catabolism. A TPO inhibition assay was optimized for use in a 384-well plate format, utilizing rat thyroid gland microsomes as the source of enzyme, and a fluorescent substrate, Amplex UltraRed, to measure enzyme activity. To determine chemical inhibition of iodide uptake, a new cell line was engineered to express the human sodium iodide symporter (NIS; hNIS-HEK293T-EPA). Uptake of radioactive iodide into these cells was measured in a 96-well format. DIO enzymes were produced via an adenoviral expression system and cell homogenates were used as source material for the 96-well plate format DIO inhibition assays. Chemical inhibition of iodide released from thyroid hormone substrates was determined by colorimetric assay. To date, these assays have been used to screen over 1,800 ToxCast chemicals for inhibitions of TPO activity, iodide uptake via NIS, and DIO enzyme activity. Data generated from this screening effort will help the EDSP incorporate potential impacts on thyroid-axis endpoints in prioritization decisions for chemicals of concern to the Agency, and inform thyroid-axis Adverse Outcome Pathway development.
Considerations for Developing and Implementing Performancebased Validation Approaches to Support ToxCast Assays
S.L. Levine, Monsanto Company / Global Regulatory Sciences
Harmonized international testing methods and principles of Good Laboratory Practices for chemical safety assessment are vital to ensure developing high quality data, reduce duplicative testing, and facilitate data sharing across governments. In 2005, OECD developed validation guidance based on a modular approach that included a test definition, intra-laboratory repeatability and reproducibility, inter-laboratory transferability, inter-laboratory reproducibility, predictive capacity, applicability domain and performance standards. The development and adoption of performance standards is intended to increase the pace of cross-validations and to limit monopolies. The performance based test guideline (PBTG) approach was initially aimed at cross-validating in vitro assays with existing performance standards. The PBTG approach has been used to cross-validate in vitro assays assessing the estrogen and androgen pathways in an HTP format in ToxCast. An important learning from this process is that for assays to be predictive, results must be interpreted considering the outcome of sensitive cytotoxicity assays. This was recently highlighted in discussions at the recent USEPA SAP on HTP androgen receptor antagonism and steroidogenesis assays being validated for ToxCast. This presentation will provide recommendations on how to effectively implement performance standards to support cross-validations for functionally equivalent assays. Broadly, these recommendations address selection of reference chemicals both positive and negative, considerations for selection of cytotoxicity assays, approaches to uncover potential confounders and perform secondary analyses for interpretation of data from cell free systems and a process to review cross-validations. Cell-based high throughput screening (HTS) technologies are becoming mainstream in chemical safety evaluations. The US Environmental Protection Agency (USEPA) Toxicity Forecaster (ToxCast TM ) and the multi-agency Tox21 Programs have been at the forefront in advancing this science, making screening results publically accessible for both research and regulatory decision-making. Initially these programs were developed with the intent of screening chemicals for hazard potential as a means to prioritize further in vivo toxicity testing for the protection of human health. Therefore, primarily mammalian-based HTS assays were developed. Subsequently, it was recognized that ToxCast screening data may be more broadly applicable for the protection of wildlife. Therefore, a challenge emerged for understanding whether these predominantly mammalian-based prioritization approaches reasonably reflect potential impacts on other species. To address this species-extrapolation challenge, the USEPA Sequence Alignment to Predict Across Species Susceptibility tool (SeqAPASS; https://seqapass.epa.gov/seqapass/) was employed. SeqAPASS evaluations comparing primary amino acid sequences and functional domains were performed for all 450 molecular targets associated with the ToxCast assays and data are being made publically available through both the SeqAPASS tool and the Comptox Chemistry Dashboard (https://comptox.epa.gov/dashboard). To demonstrate the practical application of the SeqAPASS approach to a current regulatory challenge, case studies relevant to the US endocrine disruptor screening program were developed evaluating androgen receptor, enzymes involved in sex steroid synthesis, and proteins found in the thyroid axis. Overall, conservation of these mammalian protein targets suggest that screening results identifying chemical disruption via HTS assays could be reasonably extrapolated across vertebrate species. The contents of this abstract neither constitute nor reflect official USEPA policy.
Intro to Complementary Tools
Linking High-Throughput Screening Assay Responses to Potential Hazards and Adverse Effects -Adverse Outcome Pathway Knowledge Base
S. Edwards, RTI International / Research Computing Division
Adverse Outcome Pathways (AOPs) have emerged as an ideal framework for summarizing the biological mechanisms underlying the toxicity of environmental chemicals. An AOP is described in terms of key events (KEs), which represent measurable steps along a pathway from a molecular perturbation by a chemical to an adverse outcome for an organism or population. KEs are connected via relationships (KERs), which capture the evidence supporting the AOP in a structured way. The AOP knowledge Base (AOP-KB) serves as the primary repository of AOP information globally and supports an international effort to develop AOPs organized by the Organisation for Economic Co-operation and Development (OECD). Currently, the AOP-KB consists of a set of individual modules focused on specific stages of AOP development or various uses of the AOP information. The AOP-Wiki focuses on evaluation of the evidence supporting an AOP and contains mostly qualitative information about the AOP. This module directly supports the review of AOPs by the OECD as part of the AOP Development Programme. The Effectopedia module focuses on quantitative descriptions of the AOP and allows direct incorporation of computational models based on the AOP. The AOPXplorer module focuses on AOP networks and provides additional analysis tools and data sources via the Cytoscape application platform. The Intermediate Effects Database will connect the AOP-KB to the IUCLID format required for REACH submissions in Europe and thereby provides a two-way connection for using AOPs in a regulatory context and identifying AOPs associated with chemicals in the environment. The e.AOP.portal (http://aopkb.org/) provides a single source for all information contained across the different modules with convenient search and browsing capabilities. Ecological Risk Assessment quantifies the likelihood of undesirable impacts of stressors, primarily at high levels of biological organization: populations to ecosystems. However, assessing the impact of stressors usually comes from tests on individual organisms and frequently from suborganismal studies that are often conducted at the molecular and cellular level. These tests generally cost less, are more high-throughput and minimize the use of animals. Interpreting these suborganismal data at the population or ecosystem level is challenging. We know how to relate individual responses to population dynamics using individualbased models, and there are emerging ideas on how to make connections to ecosystem services. By contrast, there is no established methodology to connect individuals to suborganismal dynamics, in spite of progress in identifying Adverse Outcome Pathways (AOPs) that link molecular initiating events to ecologically relevant key events. We are exploring the feasibility of using DEB models of individual organisms as a "pivot" connecting suborganismal processes to higher level ecological processes. AOP models quantify explicit molecular, cellular or organ-level processes, but do not offer a route to an integrated characterization of growth, reproduction, and survival. DEB models do describe these processes, but use abstract variables with undetermined connections to suborganismal biology. We propose linking DEB and quantitative AOP models by interpreting AOP key events as measures of damage-inducing processes in a DEB model. We will report on the type and structure of data that are generated for AOPs. We also report on our progress on two case studies based on Daphnia and rainbow trout that merge information collected for AOPs with DEB. For rainbow trout, we focused on endocrine disruption for which there are quantitative AOPs that integrate molecular, cellular and organ level responses to predict effects on reproduction. Connecting with a DEB required modifying the model to include feedbacks that characterize the integrated effects of hormonal control mechanisms. With Daphnia, there is little organ level data, so we seek correlative connections with transcriptomic data. Gene expression data (interpreted as key events), summarized using Principle Component Analyses appear to exhibit some molecular responses that may correlate with parameters controlling relevant DEB fluxes. The Environmental Risk Assessment (ERA) framework provides a systematic approach to evaluate the environmental risk of a contaminant. ERA practices can differ between countries/regions, as these decisions are based on science but implemented as policy. Some differences include: accepted test species, required testing approaches/guidelines, and the magnitude of applied assessment factors. Global industries are challenged to perform toxicity tests that would have the widest global acceptability in order to save animals, time, and money. Broad regulatory acceptance in ERA is therefore key when considering alterations in the ERA framework. Here, we discuss several ways that HTS data could be incorporated into an ERA, including: 1) directly replacing a required toxicity endpoint (unlikely to be successful), 2) provide a WOE for refining applied assessment factors, 3) provide a WOE for MOA assignment, 4) building computational models to predict highly toxic compounds ("showstopper" tests) or MOA specific effects (e.g. ER agonism). Several key caveats to HTS in ERA will be explored. Many ERAs are built only on acute toxicity information (algal, invertebrate, and fish). HTS data and models have been largely focused on vertebrates/mammals. However, ERAs are most frequently driven by algal or invertebrate results. Finally, we will present a case study on alcohol sulphates; from a positive YES assay result to follow-up analysis and in vivo experiments. The challenges of using HTS screening approaches for surfactants will also be discussed. Chemical companies employ early screening methodologies during chemical research and development to screen out chemicals that show signs of unwanted toxicological hazards or a poor environmental fate profile. These early screens include a combination of in silico tools and in vitro assays that are designed around key events or indicators linked to adverse outcomes or undesirable environmental fate parameters (e.g. PBT, endocrine disruption, sensitization). The results from early screens can be used to guide subsequent testing, including in vivo evaluations which are required, in many cases, for chemical registration in different geographies. In order to provide guidance on the conduct and interpretation of data from diverse sources (e.g. phys/chem parameters, in silico, in vitro, and in vivo data) integrated approaches to testing and assessment (IATA) have been developed for endpoints that are critical for evaluating safety for human health and the environment. Several IATAs that have been developed within the chemical industry will be presented, including those associated with endocrine activity, bioaccumulation, and ecotoxicity. The role of in vitro screens in these IATAs will be emphasized, and data gaps, where they exist, will be noted. Several chemical case studies and their evaluations in relevant IATAs will be presented with associated learnings and recommendations for future improvements. 
Individual Chemical Assessments
In Vitro Screening and Integrated Approaches for Testing and
Song, Norwegian Institute for Water Research / Ecotoxicology and Risk Management
A number of exogenous compounds have the potential to interfere with the endocrine system of animals and may perturb vital endocrine processes to a degree causing an adverse effect (outcome) on ecologically relevant endpoints such as growth, development and reproduction. These endocrine disrupting (ED) effects have been well characterised in aquatic vertebrates and mammals due to a well-defined endocrine system and substantial research effort in the last decades, but knowledge on ED effects in a larger range of species are still poorly characterized. Lack of knowledge and availability of suitable bioassays is currently major limiting factors for high-throughput screening, chemical prioritization and risk assessment of endocrine disrupting chemicals (EDCs) in aquatic non-verterbates such as crustaceans. The present project have focussed on developing Adverse Outcome Pathways (AOPs) for EDs in aquatic arthropods, and applying these to assess the hazard and risk of single chemicals and ecologically relevant complex mixtures of pollutants. Although several ED mechanisms have been proposed to be of relevance for crustaceans, perturbations of endocrine processes related to chemical interactions with the ecdysone receptor (EcR) and the Juvenile Hormone (methyl farnesoid) receptor (MfR) have been identified to be of particular concern. The present paper focus on the application of AOPs to 1) characterise the linkage between endocrine mechanisms and adverse outcomes, 2) develop and use in silico, in vitro and in vivo testing strategies, 3) screen and identify priority EDCs from large chemical inventories for priotization purposes, and 4) perform cumulative hazard and risk assessment of ecologically relevant exposure scenarios. A detailed descruiption of approaches, deliverables and data generated from the project is provided at www.niva.no/edrisk. Acknowledgement -Funding from RCN-221455 "Adverse Outcome Pathways for Endocrine Disruption in Daphnia magna, a conceptual approach for mechanistically-based Risk assessment (www.niva.no/edrisk)", RCN-268294 "Cumulative hazard and risk assessment of complex mixtures and multiple stressors (www.niva. no/mixrisk)" and EU-FP7 project SOLUTIONS (http://www.solutionsproject.eu/project/).
Case Study: High-Throughput Screening Applied to Hazard and Effects Assessment for Environmental Risk Assessment
D.T. Chang, USEPA / Office of Chemical Safety and Pollution Prevention / Office of Pollution Prevention and Toxics / Risk Assessment Division
Recent amendments to the Toxics Substances Control Act (TSCA) have led the United States Environmental Protection Agency (USEPA ) to consider new approach methodologies (NAM) in many aspects of TSCA implementation. Data generated from NAMs such as High-Throughput Screening (HTS) coupled with in silico approaches may potentially benefit chemical prioritization efforts under TSCA by providing the ability to 1) analyze large volumes of data and compare them across multiple lines of evidence to predict the effect of chemicals on human health and the environment, and 2) identify data gaps in the chemical data landscape necessary for conducting risk evaluation. However, challenges exist in the interpretation and use of NAM data such as HTS within these efforts. Current case study with an emphasis on chemical prioritization and risk evaluation will be discussed with specific considerations for the use of HTS data within current Ecological Risk Assessment paradigms. The views expressed in this abstract are those of the authors and do not necessarily represent the views or the policies of the U.S. Environmental Protection Agency. High throughput screening databases such as ToxCast can effectively and efficiently be used to screen chemical exposure data to prioritize among multiple chemicals and sites for potential biological effects. With the steady advancements in analytical chemistry techniques of the past two decades, it has become common to achieve very low levels of detections in the ng/L and even pg/L ranges for organic compounds in environmental matrices. With these low detection levels, the increasing number of organic compounds that can now be quantified, and the relatively small percentage of those compounds that have established environmental exposure benchmarks (e.g., water quality guidelines), it is a challenge to determine the biological relevance of exposure. In addition, environmental exposure benchmarks and available toxicity endpoints are commonly derived from in-vivo assays that vary from chemical to chemical, using different organisms, durations, and other test conditions, making comparisons among chemicals difficult. High throughput screening results from the ToxCast program provide a means to expand the number of chemicals that can be evaluated, while at the same time providing information from a more consistent suite of assays than information from traditional benchmarks or in-vivo assays. As an assessment of potential biological influence from monitored trace organic chemicals in Great Lakes tributaries, exposure:activity ratios (EAR) were computed as EAR = (chemical concentration)/(ToxCast Endpoint). Resulting EAR values for 901 water samples, 301 chemicals, and 59 sites were computed and used for assessment of potential biological influence in a spatial context, by specific site, by individual chemical, by chemical class, by ToxCast endpoints, and by selected annotations in the ToxCast database. ToxCast endpoints from the most prominent EAR values were used as guides for evaluating putative adverse outcome pathways. The contents of this abstract neither constitute, nor necessarily reflect, official USEPA policy. We evaluated whether advanced treatment of wastewater (disinfection) and stormwater effluents (iron enhanced filtration) improved removal of contaminants of emerging concern and associated toxicities. Workflow for two studies was similar. Composite water samples were collected from pre-, and post-treated effluents. Their chemical composition and the effects on a variety of molecular targets (25 human nuclear receptors; NRs) and 46 transcription factors/pathways; FACTORIAL platform, Attagene, Inc) were evaluated. Chemistry data was integrated with the publically available toxicity data (ToxCast) to predict whether treatmentrelated decreases (and increases) in chemical concentrations would "make any difference" to biological receptors. Outcomes of these "in silico" predictions and the empirical in vitro data were compared for consistency. Control water, and pre-and post-advanced treatment effluents were also used to conduct short-term exposures with fish (wastewater) or Daphnia (stormwater); transcriptomic and metabolomics analyses of these samples are partially completed. In silico predictions identified nuclear receptors (well-characterized targets such as estrogen receptor in particular) as the most sensitive and likely to be affected by the exposure; empirical in vitro data supported this prediction. However, in vitro data pointed to additional chemical drivers of toxicity; many of the molecular targets covered by ToxCast were not indicated by predictive toxicology analyses, but were activated in vitro (e.g., peroxisome proliferator activating receptor (PPRE) and glucocorticoid receptor (GR)). In vitro and in vivo toxicity assessments also indicated that treatment-related reductions of parent chemicals are not always paralleled by toxicity reductions. These findings emphasize the importance of characterizing transformation products associated with the wastewater disinfection and stormwater treatment, and highlight the advantages of combining analytical and high-throughput bioeffects approaches to evaluate treatment effectiveness. We are currently integrating analytical chemistry and empirical toxicity data using association rule learning to advance understanding of chemical drivers of wastewater and stormwater toxicity.
High-Throughput Screening Data in Risk-based Prioritization of Environmental Samples
Pilot Testing Cell-based Receptor Assays to Screen for Emerging Contaminants and Assess Risks in Aquatic Ecosystems
A.C. Mehinto, Southern California Coastal Water Research Project / Toxicology; K.A. Maruya, SCCWRP
Current monitoring programs target individual groups of chemicals for which robust analytical methods exist, but do little to address the presence of unexpected chemicals (e.g. metabolites, transformation products). This chemical-by-chemical assessment paradigm doesn't take into account the potential ecotoxicological risk that complex chemical mixtures present. High throughput cell-based assays have shown promise as bioscreening tools to assess environmental mixtures. In recent years, studies have successfully used these assays to benchmark water of different qualities and prioritize sites requiring further chemical and/or toxicity testing. To evaluate their utility in monitoring programs, ecologically relevant cell assays were evaluated and optimized. Validated protocols were then applied to screen aqueous samples from various environments including freshwater streams, sediment, wastewater effluents, and fish tissues. Results of these studies indicated that wastewater effluents had the highest levels of endocrine activity followed by samples from effluent-dominated rivers, while most streams analyzed showed little to no bioactivity. Cell assay results compared favorably to the targeted chemistry data. To evaluate the potential of cell assays for toxicity screening, the relationship between bioactivity and animal/community responses were examined. Altogether, the findings demonstrated that cell assays can provide valuable information on both occurrence and biological impact of contaminants in the environment. 
Application of High-Throughput Screening Assays to Environmental Samples 28 EU SOLUTIONS Project -Application of High-Throughput Screening for Water Quality Monitoring and Effect-directed Analysis
SOLUTIONS (2013 to 2018) is a European Union Seventh Framework
Programme Project (EU-FP7). The project aims to deliver a conceptual framework to support the evidence-based development of environmental policies with regard to water quality. SOLUTIONS will develop the tools for the identification, prioritisation and assessment of thosewater contaminants that may pose a risk to ecosystems and human health. To this end, a new generation of chemical and effect-based monitoring tools is developed and integrated with a full set of exposure, effect and risk assessment models. Equally, SOLUTIONS and other projects in close co-operation with the NORMAN network have achieved considerable progress and harmonized approaches with regard to -Standardization of test systems, -Availability of robust enrichment tools, -Demonstration and evaluation in case studies, -Development of trigger values. -Development of HTS which lead to great confidence that effect-based methods are ready for implementation into routine water monitoring. Effect-directed analysis (EDA) as a combination of biotesting, sequential fractionation and subsequent analytical identification of toxicants in active fractions has been successfully applied as a tool for the identification of drivers of toxicity in complex environmental mixtures including water, sediment and even biota. EDA has been shown to be very helpful in establishing cause-effect relationships at specific sites of concern where significant adverse effects have been observed. Thus, the approach has already been suggested as na relevant tool for toxicant identification after effect-based monitoring in the context of WFD implementation. However, although automation and integration of biotesting, fractionation and analysis in EDA may significantly enhance the throughput of this methodology, the approach is still time-consuming. The presentation will give an overview on the application of HTS for water quality monitoring and effect-directed analysis within the SOLUTIONS project and the NORMAN network. A special focus is given on the development of high throughput in vitro bioassays for determination of the CYP450-inducing potential of samples using chemically defined media and suspension cell culture. Bioassays can be used to evaluate the integrated effects of complex mixtures of both known and unidentified contaminants present in environmental samples. Most bio-monitoring approaches have historically focused only on one or a few pathways (e.g. estrogen receptor, androgen receptor) despite the fact that the chemicals in a mixture may exhibit a range of biological activities. High-throughput screening approaches that can rapidly assess samples for a broad diversity of biological activities offer a means to provide a more comprehensive characterization of complex mixtures. In the current study, surface waters samples from 38 sites were screened through two multiplexed in vitro assays as part of a nationwide stream assessment. Between both assays, 69 target endpoints were screened covering 59 unique gene targets. In total, 26 endpoints demonstrated borderline activity above extract blanks (>1.25-fold induction), and 11 of these endpoints were active above baseline (>1.5-fold induction) in two or more samples. Active biological targets include aryl hydrocarbon receptor, estrogen receptor, glucocorticoid receptor, and pregnane X receptor. The number of registered National Pollution Discharge Elimination System (NPDES) sources and percent of watershed classified as "developed, low intensity" were both significantly correlated with bioactivities, suggesting point and non-point anthropogenic sources as contributors to observed bioactivity. Reported contaminant concentrations and assay bioactivity were further evaluated to identify potential associations between bioactivity and specific chemicals. Estrogen receptor activity was the only endpoint well predicted through exposure-activity analysis. Sparse partial least squares (SPLS) analysis identified 48 unique contaminants associated with bioactivity, suggesting potential surrogates of biological effect that could be used to prioritize locations with available chemical monitoring data for subsequent bioeffects monitoring. Overall, the results highlight the applicability of multiplexed in vitro bioassays to environmental monitoring and identify biological targets to focus development of adverse outcome pathways (AOPs) to better understand the consequence of increased biological activity in surface waters. The contents of this abstract neither constitute, nor necessarily reflect, official USEPA policy.
In Vitro Bioassays for Monitoring of Wastewater Treatment Effluent
I. Werner, Ecotox Centre Eawag-EPFL / Department of Anatomy Physiology and Cell Biology; C. Kienle, Ecotox Centre Eawag-EPFL; E. Vermeirssen, Ecotox Centre Eawag-EPFL / Aquatic Ecotoxicology
Emerging pollutants in wastewater, such as e.g. pharmaceuticals and personal care products, can be eliminated by advanced wastewater treatment techniques. Thus the discharge of these substances into freshwater ecosystems can be diminished and drinking water resources can be protected. Previous studies have shown ozonation and active carbon filtration to be promising advanced technologies to eliminate micropollutants still present after conventional wastewater treatment. Here we present results of several studies focused on monitoring the efficacy of wastewater treatment technologies by measuring the effects of micropollutants present in wastewater using in vitro bioassays. The investigations revealed that wastewater treatment with ozone as well as active carbon resulted in significantly reduced ecotoxicological effects, improved growth and photosynthesis of green algae, decreased toxicity to luminescent bacteria, and decreased estrogenicity, compared to effects measured in wastewater samples collected from the secondary clarifier. Additional post-treatments led to a further decrease of the effects in some cases. Measurement of ecotoxicological effects in the field confirmed the influence of wastewater effluent on water quality of streams, but also showed that non-point source pollution is an important factor to take into account.
Mixture Toxicity Modeling to Link Chemical Concentrations to High-Throughput Screening Data of Environmental Samples and for Deriving Effects-based Trigger Values
B. Escher, Helmholtz Centre for Environmental Research GmbH -UFZ / Cell Toxicology
In vitro bioassays including cell-based bioassays and low-complexity whole-organism assays have been applied for decades in water quality monitoring and more recently HTS tools have become available and with them large datasets of effect data for single chemicals. We can make use of single chemical effect data for linking analytical concentration to predicted effects of the detected chemicals by using the concept of bioanalytical equivalent concentration (BEQ) that is based on the mixture model of concentration addition, which is applicable for many reporter gene assays. The BEQ chem from chemical analysis can be compared to the BEQ bio directly quantified in water samples. The gap between BEQ bio and BEQ chem (i.e. BEQ unknown ) constitutes the effects elicited by unknown chemicals. As several field studies demonstrated, for hormone receptors and other highly specific effects, known chemicals typically explain the majority of the observed effects but the analysis of adaptive stress responses, activation of metabolic enzymes and apical effects quantified large fractions of effects caused by unidentified chemicals. Hence bioassays can yield information on chemicals that are not identified or not routinely quantified to obtain an overall estimate of the chemical risk in a water samples. However, there is no common agreement what level of response is acceptable. As of now, bioassay results were only benchmarked against each other but not against an absolute measure of chemical water quality. The EU environmental quality standards (EQS) differentiate between poor and acceptable surface water concentrations for individual chemicals of concern but cannot capture the thousands of chemicals in water and their biological action as mixtures. We developed a method for the definition of effect-based trigger methods (EBT) that reads across from existing EQS and makes additional mixture considerations to assure that the derived EBT are protective for complex mixtures as they occur in surface water. The EBT derivation method was applied to >30 in vitro bioassays and tentative EBTs were derived, In various water quality monitoring studies, the proposed EBTs were able to differentiate wastewater from surface water. Despite limitations, the proposed generic method to derive EBTs is a first step to harmonise existing approaches and explore various different options of a large diversity of in vitro bioassays commonly applied for water quality assessment.
Monday Posters -High Throughput Approach MP001 A Cell-Free Neurochemical Assay to Screen Chemicals Across Fish, Birds, and Mammals
N. Basu, McGill University / Department of Environmental Health Sciences; A. Arini, McGill University
An estimated 30,000+ commercial chemicals are believed to possess neurotoxic properties. As current animal studies are expensive, timeconsuming, and overlook many at-risk organisms, development of new screening methods is required. In vitro, cell free assays have potential as relatively inexpensive, screening mechanisms to flag neurotoxic compounds. The objective of this study was to advance a cell-free, neurochemical-based screening assay platform, and to apply it to study 20 species of birds, fish, and mammals, and screen against ~900 chemicals. In Phase 1 of this project, we screened 80 known environmental chemicals (metals, pesticides, personal care products, flame-retardants) against key receptors and enzymes from the glutamatergic, GABAergic, dopaminergic, and cholinergic neurochemical pathways, and did so in multiple taxa including fish (king mackerel, yellowfin tuna, goldfish, rainbow trout, perch), birds (bald eagle, Japanese quail, chicken, zebra finch), mammals (river otter, mink, pilot whale, common dolphin, narwhal, ringed seal, polar bear), and biomedical species (rat, mouse, human). In Phase 2 of this project we took a sub-set of Phase 1 "hits" and derived concentration-response curves. In Phase 3 of this project, we focused on a subset of species and neurochemical endpoints, and screened the USEPA E1K library of 800 chemicals. In this presentation, in addition to presenting our results we will 1) elaborate on the execution of such cell free assays and discuss 'pros and cons' of our screening method; and 2) discuss a strategy by which large volumes of in vitro data outputs may be modeled to predict individual-based adverse outcomes pathways. Currently, ecological risk assessment relies heavily on data from standardized tests that use invertebrate and piscine species. Although birds are a sensitive indicator of ecosystem health, avian toxicity data for many chemicals of environmental relevance are limited. The overall goal of our research project is to assess the effectiveness of avian early-life stage toxicity testing for rapidly screening chemicals of ecological and regulatory concern. Here, we utilize an avian egg injection protocol and use it to assess 8 chemicals (benzo [a] [CPF] ) that are commonly detected in Canadian ecosystems and have well-characterized modes of toxic action. The chemicals were dissolved in dimethyl sulfoxide and injected into the air cell of Japanese quail (JQ) embryos prior to incubation at three concentrations; the highest aiming to cause 20% lethality based on literature reviews. Liver tissue was collected from a sub-set (n=5/dose group) of embryos at mid-incubation (day 9) for subsequent 'omics and analytical chemistry analyses. The remaining embryos were examined on day 16 (1-2 days prior to hatch) for deformities, growth and health metrics. Mortality in the vehicle group was low across all experiments (3%), and was below the 20% target for EE2, CPF, and Pb (14, 9, and 6 % respectively). BaP was embryotoxic at the highest dose tested (0.5 µg/g) resulting in 50% mortality. EE2 and CPF exposure reduced embryo growth (at concentrations of 33.3 and 40 µg/g egg, respectively) and CPF caused an increase in gallbladder size and increased incidence of deformities of the feet and spinal cord. Pb exposure resulted in a low occurrence of eye abnormalities at 1µg/g. Results for SeMe, HBCDD, FXH and TB are pending. Overall, the effects of chemical exposure in JQ were consistent with predicted toxicity profiles from other species. The use of avian embryos prior to hatch helps address the need to replace live animal tests with alternative approaches for chemical screening. The co-determination of apical and 'omics end points will greatly contribute to ecological risk assessments and the development of adverse outcome pathways. Here we introduce ToxMine as a unique online platform integrating diverse resources of toxicogenomics data to systematically characterize gene expression signatures and chemical structural features that are associated with different toxicity measurements. By coupling several cutting-edge distance/similarity measures with network-based approaches, ToxMine allows researchers to quickly identify known or potential toxicity effects from multiple queries such as chemical names/structures, SMILES strings, list of significant genes or gene expression data. The underlying knowledge base is based on data curated from Tox21, ACToR, LINCS L1000 and CTD with links to PubChem and other compound databases. ToxMine has been implemented as a high-performance cloudbased web application with intuitive interface to allow users to easily browse, search, analyze and visualize their results to gain deep biological and mechanistic insights. ToxMine is designed for toxicologists, biologists, biochemists, and clinicians who are interested in getting useful information about possible adverse effects for a set of provided chemicals or gene signatures. ToxMine is freely available at http://www.toxmine.ca.
MP002 Characterization of Developmental Effects of Eight Environmentally Relevant Chemicals Using an Early-Life
MP003
MP004 Development of Real-Time Human Cell Analysis Method for Identification and Categorization of Genotoxic Chemicals
D. Guimet, Y.A. Abassi, D. Santa Ana, C. Jin, ACEA Biosciences
One of the major challenges in genotoxicity testing is to design appropriate tests which rely on a comprehensive cellular mechanistic understanding of the mode of action of toxicants. Importantly, genotoxic tests must provide reliable and reproducible information to assess human health risks associated with exposure to genotoxic and carcinogenic compounds. Based on endogenous signaling pathways of cells responding to genotoxicants, an impedance-based Real Time Cell Analysis (RTCA) method is developed to capture the overall changes in cell number, morphology and adhesion using human Beas2B and HepG2 cells. The screening approach integrates RTCA with micronucleus (MN) flow assay in HepG2 to detect DNA damaging substances, while simultaneously monitoring cytotoxicity and potential mechanism of action. The screening approach was validated using 52 reference compounds encompassing 17 clastogens, 4 aneugens, 9 mutagens and/or nucleoside analogues, and 22 non-genotoxic substances. The results indicate that the screening approach identifies genotoxicants with high specificity: mutagens and clastogens display a unique kinetic response profile on RTCA, while aneugens display another distinctive kinetic response profile. In addition, RTCA allows for direct monitoring of multiple doses to set a threshold for concentrations that are too toxic to be analyzed by MN flow assay, and provides an accurate doubling time of the cell population. Following RTCA analysis, an Autosampler is integrated on the flow cytometer (FC) that allows the same microtiter plate to be used for RTCA, sample processing, and MN flow analysis. In addition, the FC incorporates a volumetric cell count to provide accurate viability data without the need for reference beads. By incorporating micronucleus flow assay, tested substances can be further divided into four classes: mutagen, clastogen, aneugen, and non-genotoxic. This is the first in vitro assay using mammalian cell system to capture all different subgroups of genotoxic agents, in a high-throughput manner. The data suggests that RTCA and MN flow assay can be integrated to detect compounds that directly target DNA, differentiate between distinct mechanisms of action, whilst providing additional assessment on viability, cell cycle, and cytotoxicity, within a single workflow. Overall, this workflow is efficient and can be used as a first tier of screening to identify potential genotoxic activities. Given the large amount of potential data (10 M chemical vs assay points) there is a push to apply High Throughput Screening data to (regulatory) environmental assessment. Data interpretation however has proven to be a stumbling block in applying HTS data towards environmental regulation. Direct testing of actual environmental samples allows for access to HTS data for environmentally relevant mixtures. Interpreting assay data outside an AOP framework remains difficult. A relatively small proportion of assay/chemical combinations have been used in construction of AOPs although that use is increasing rapidly. While such AOPs are being constructed what other assessments (regulatory or not) can HTS be used for? The current study devised a method for utilizing the HTS data output from ToxCast USEPA for hazard assessment of tested chemicals. For this pilot study the focus was placed on the assay's intended target organ family and the intensity of the level of active hits. Using the intended target family, chemicals under ToxCast and Tox21 can be sorted by target organ and/or toxic effect. Chemicals can also be scored based on the organ effect level and intensity value (active hits vs inactive hits). An additional consideration was cytotoxicity level, as cytotoxicity can mask the probable positive assay endpoints at higher concentrations. As a proof of concept, this poster will use selected data inputs to "score" hazard endpoints, while exploring possible (regulatory) hazard assessment applications. A drawback of current in vitro chemical testing is that many commonly used cell lines lack chemical metabolism. To address this challenge, we present a method for assessing the impact of cellular metabolism on chemical-based cellular toxicity. A cell line with low endogenous metabolism (HEK293T) was engineered to overexpress cytochrome P450 monooxygenase (CYP) recombinant transgenes prevalent in human liver (CYP1A1, CYP1A2, CYP2E1, and CYP3A4). Each of the five clones (four CYPs and one empty vector control) were mated to unique DNA barcodes and used as surrogates of cell viability that could be distinguished in a mixed clonal culture by PCR. Four known cytotoxic chemicals (rotenone, fluazinam, galangin, and zoxamide) were assessed. We evaluated general cytotoxicity on individual clones using CellTiter-Glo (CTG) and CellTiter-Blue (CTB). Toxicity was observed with both assays for all chemicals tested (p< 0.05 vs. DMSO controls; two-tailed t-test), however CTG results did not agree with observable cell loss after rotenone (9% vs. ~60% loss) and galangin (12% vs. ~65% loss) exposures. Morphological characteristics indicated different necrotic, apoptotic, or a combination of cell death mechanisms mediated by these chemicals, partially explaining assay discrepancies. To assess the cytotoxic impact on individual clones, DNA was isolated from dosed cells and barcodes were quantified using equal volumes by digital droplet PCR (ddPCR) in a mixed clonal culture. A strong correlation (Pearson's r = 0.29-0.93, x = 0.69) between total DNA concentration and individual DNA barcode counts was observed, suggesting barcode counts were representative of DNA isolated. However, the predicted monotonic loss of DNA due to lower cell viability was not observed, suggesting these measurements were not representative of individual clonal toxicity. Further, preliminary data noted differences in measured chemically-induced cytotoxicity due to plate coating used. We speculate this discrepancy is the result of excess DNA retained in the extracellular matrix which may be influenced by the mechanism of cell death and/or plating matrix. Future optimization of cell culture conditions and efficient washing of DNA associated with non-viable clonal cells will be necessary to refine this method. The overall goal will be to adapt this barcode method as a high-throughput screen to rapidly assess CYP-mediated chemical toxicity. This abstract does not necessarily reflect USEPA policy. The Fischer rat thyroid follicular cell line, FRTL-5, expresses the sodium iodide symporter (NIS) natively and has been widely used to study thyroid function. Here the FRTL-5 cell line was evaluated for its use in the radioactive iodide uptake (RAIU) assay as an orthogonal test to our previously developed human NIS (hNIS) in vitro screening for NIS inhibitors. The FRTL-5 RAIU assay was first optimized in a 96-well format over a 2-hr exposure period, and validated with a set of known NIS inhibitors and inactive compounds. Then 18 selected ToxCast chemicals previously identified as potential hNIS inhibitors in a high-throughput screening (HTPS) were retested in the FRTL-5 RAIU assay with these chemicals obtained from a new source. Chemicals (0.001-100µM) were tested in parallel RAIU and cell viability assays across 3 independent biological replicates. Results from assay controls, as well as reference and test chemicals, demonstrated robust, highly reproducible performance of FRTL-5 RAIU and cell viability assays. Seventeen of the 18 chemicals confirmed significant RAIU inhibition in the FRTL-5 assay with some exhibited varied potencies in comparison to the hNIS assay. These data demonstrate the utility of an orthogonal RAIU assay, with a physiologically relevant thyroid follicular cell line capable of endogenous NIS expression, to further investigate chemicals identified in HTPS for NIS inhibition. Moreover, the FRTL-5 cell line allows a species comparison (rodent versus human NIS), and detection of activity in newly sourced chemicals strengthens the screening and testing paradigm. Chemicals displaying strong NIS inhibition in both the FRTL-5 and hNIS RAIU assays will be prioritized for additional testing using in vitro/in vivo assays to characterize the mechanism of inhibition and potential impact on thyroid hormone synthesis. This abstract does not necessarily reflect USEPA policy. The USEPA Office of Research and Development (ORD) is currently evaluating HTS assays to identify chemicals that disrupt thyroid hormone (TH) homeostasis. One key focus is the human sodium/iodide symporter (hNIS) as this transmembrane glycoprotein mediates iodide uptake into the thyroid to initiate TH biosynthesis. An HTS approach utilizing a NIS-expressing cell line (hNIS-HEK293T-EPA) in parallel radioactive iodide uptake (RAIU) and cell viability assays was previously employed to evaluate a test set of 50 chemicals including well-characterized NIS inhibitors. Here, the ToxCast Phase I and II chemical libraries were screened for potential inhibitors of iodide uptake where 1087 blinded samples were first assessed in the RAIU assay at a single concentration of 100µM. Using 20% inhibition of iodide uptake as a threshold for further investigation, 404 samples were then tested at 6 concentrations ranging 0.001 -100µM in parallel RAIU and cell viability assays. Of these, 305 samples exhibited significant inhibition of iodide uptake while the remaining 99 samples were negative. Samples were subsequently ranked as potential NIS inhibitors using a unique scoring system to sort the RAIU inhibition potency of a sample relative to the inhibition potency of sodium perchlorate (positive control for NIS inhibition) and the cytotoxic effect of the sample. Some of the highest ranked chemicals have been previously implicated as TH disruptors, including PFOS, nitrofen, tributyltin chloride, and triclocarban. This scoring system will be utilized across ToxCast chemical libraries in effort to prioritize chemicals for further evaluation with additional in vitro and in vivo methods. This abstract does not reflect USEPA policy.
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MP009 Optimization and Application of an Image-based Phenotypic Profiling Assay to Estimate In Vitro Points-of-Departure for Chemical Bioactivity
J. Nyffeler, C. Willis, J. Harrill, USEPA / Office of Research and Development / National Center for Computational Toxicology
Imaging-based phenotypic profiling is a high-throughput screening method that combines automated microscopy and image analysis to measure a large variety of features at the single cell level. Here, we describe workflows for concentration-response screening, image analysis and calculation of in vitro point-of-departure (POD) estimates using a phenotypic profiling assay that evaluates changes in organelle morphology. MCF7 or U-2 OS cells were plated in 384-well plates. After 24 h, cells were treated with 7 concentrations (0.1-100 µM, n = 3/plate, 3 independent plates) of 16 reference chemicals in a randomized pattern using an Echo 550 acoustic dispenser. After 48 h of treatment, cells were live labeled with MitoTracker (mitochondria), fixed, permeabilized and labeled with Hoechst-33342 (nuclei), SYTO14 (nucleoli) and fluorescent conjugates of concanavalin A (ER), phalloidin (actin cytoskeleton), and wheat germ agglutinin (Golgi/plasma membrane). A multiplexed cell viability and apoptosis assay was run in parallel. Confocal images were acquired using an Opera Phenix HCS system and analyzed using Harmony software, yielding > 300 features per cell. Cell-level data were median absolute deviation (MAD) normalized using DMSO controls. Benchmark dose (BMD) modeling was performed on well-level median values with BMDExpress 2.0. Most chemicals (n=13) significantly affected cell morphology. Distinct patterns of affected cellular features were observed across the chemical set and, in most cases, were consistent with observations from the literature. Changes in the actin cytoskeleton/ Golgi/plasma membrane (AGP) domains were the most sensitive for Ca-074-Me, fluphenazine and tetrandrine, whereas the DNA/RNA, mitochondria, ER and DNA/morphology domains were the most sensitive for fenbendazole, berberine chloride, oxibendazole and taxol, respectively. For a subset of chemicals, phenotypic profiling BMDs were well below cytotoxicity BMDs. Most chemicals produced similar profiles in both cell lines, however, U-2 OS were more sensitive to a subset of chemicals. In summary, the described protocol was successfully applied to MCF7 and U-2 OS cells using automated liquid handling tools. Testing of diverse compounds yielded distinct patterns of affected parameters below the threshold for cytotoxicity, indicating that this test method could be used to derive conservative in vitro PODs for screening level risk assessments. This abstract does not necessarily reflect USEPA policy.
MP010 Automated Data Extraction in Toxicological Systematic Reviews: A High-Throughput Approach
A. Varghese, M. Cawley, J.S. Trgovcich, ICF
Systematic reviews require the identification and synthesis of data from all available evidence related to a review question. Conducting a systematic review requires a comprehensive literature search, screening to prioritize relevant literature, data extraction, risk of bias evaluation, and various meta-analyses related to questions of interest. The most expensive and time-consuming aspects of systematic review relate to data extraction, in which subject matter experts must manually review full text documents to extract specific data elements. Although natural language processingbased information retrieval technologies are now widely used to increase the efficiency of the literature screening and prioritization step, the use of machine learning based information extraction algorithms in the data extraction step is still limited. In this research, we use published evidence tables from USEPA's IRIS assessments, together with the corresponding full text articles, to test the accuracy of a combination of information extraction algorithms on a series of structured data elements. Specifically, we use a combination of natural language processing based sequence labelling algorithms, supervised machine learning based text analytics algorithms, and string search based hand-crafted rules to extract structured data elements including species, strain, route of exposure, dosing regimen, and chemical. Extracted elements included sentences, in which the sentence containing the information relevant to the data element is extracted, and entities, in which the specific entity is fully extracted. By comparing the machine extracted results to the expert curated results in the published evidence tables for the identical set of studies, we find accuracy rates ranging from 55% to 93%. We present the comparative performance of the various algorithms tested individually and in a pipeline, and assess the effect of training data size. We estimate potential time savings from the use of automated data extraction algorithms and, based on our presented empirical findings, propose a framework for a high throughput approach to toxicological systematic reviews.
MP011 Using Machine Learning and SWIFT-Active Screener to Reduce the Expense of Evidence Based Toxicology
B.E. Howard, A. Tandon, J. Phillips, M. Shah, D. Mav, R. Shah, Sciome LLC
Evidence-based toxicology employs the rigorous and transparent methodologies of Systematic Review (SR) in order to synthesize and reach consensus about targeted questions related to the health effects of environmentally important chemicals. A critical and time-consuming step in this process is screening the available literature to select relevant studies for further analysis. We have recently evaluated our collaborative, web-based screening tool, SWIFT-Active Screener, in order to assess its ability to reduce the overall screening burden associated with creating and maintaining a systematic review. By employing a machine learning methodology called "Active Learning", and through a novel statistical method that can accurately estimate the percentage of relevant studies screened, Active Screener can significantly reduce the overall screening burden compared to traditional approaches. Previously, we have demonstrated the theoretical advantage of using Active Learning to priority rank documents by simulating the review process using a large set of more than 100,000 titles and abstracts already screened by human screeners during 20 different systematic reviews. Compared to traditional screening, this method resulted in an average 54% reduction in screening burden, while still achieving 95% recall or higher; when tested on a subset of the 13 studies containing >1,000 articles, the reduction in screening burden improved to 71%. Here, we extend that work by evaluating the performance of our SWIFT-Active Screener application on several recent systematic reviews conducted using our software by organizations such as NIEHS, USEPA, USDA, TEDX and EBTC. Results from these "real world" data sets are similar to results previously observed in simulation. For example, in the largest of the projects evaluated, 20,883 references were dual-screened using Active Screener, with 99% recall achieved after screening only 42% of the total collection. Given that each abstract takes, on average, 1 minute to screen per screener, the resulting savings in effort for this review alone was approximately 400 hours. More than 4,000 systematic reviews are performed each year in the fields of environmental health and evidence-based medicine, with each review requiring, on average, between six months to one year of effort to complete; for this reason, we anticipate that machine learning screening tools such as Active Screener can help to greatly reduce the total cost of evidence-based toxicology. Recent studies have revealed that in addition to chemicals with unknown mode of action (MoA), especially neuroactive compounds such as certain pesticides, pharmaceuticals and industrial chemicals represent the largest biologically active group in major European rivers. Bioanalytical, effectbased tools such as the acute fish embryo toxicity (FET) test (OECD test guideline 236) provide a direct link between exposure and biologicaleffects. However, given the high diversity and mostly low environmental concentrations of anthropogenic chemicals, the sole consideration of lethal endpoints does not allow for quantitatively adequate ecotoxicological assessment of environmental exposure. We therefore aim at improving the sensitivity of the acute FET test in order to detect sublethal effects of environmentally relevant chemicals using behavior-based approaches. To achieve this, a set of compounds with various MoAs was analyzed applying a light-dark transition locomotor response test with zebrafish (Danio rerio) at early larval stage. Indeed, during the exposure period under study, responses in behavior were more sensitive than lethal endpoints in most cases. Furthermore, we found that exposure-induced behavioral alterations were not restricted to compounds known and/ or developed to impact on neurological targets but also non-neurotoxic and even test species-unspecific compounds such as herbicides and fungicides. Although the background of these observations remains largely unexplained at this point, these results indicate that the application of behavioral assays to the assessment of neuroactive potentials of complex chemical mixtures such as environmental samples cannot necessarily be traced back to known neuroactive substances. Furthermore, we found that chemicals with the same MoA do not necessarily provoke similar behavioral phenotypes. Therefore, high-throughput screening methods covering a wider spectrum of compounds and compound properties may provide a more comprehensive picture of behavioral responses to chemical exposure and underlying mechanisms.
MP012 Behavioral Profiling of Environmental Contaminants Using a Zebrafish (Danio rerio) Locomotor Response Assay
MP013 Considering Tox21 in Ecological Risk AssessmentPreliminary Investigation into the Zebrafish Embryo Assay
C. Inglis, J. Prindiville, M. Belair-Bambrick, M. Jagla, Environment and Climate Change Canada; R.L. Dalton, Environment and Climate Change Canada / Department of Biology
While advances in toxicity testing have led to a rise in the application of in vitro and high throughput screening (HTS) data in human health risk assessment, few HTS assays in the Tox21 program are conducted in ecologically relevant species. Two exceptions are the HTS zebrafish embryo tests (ZFET). The ZFET uses live embryos and measure several endpoints that include mortality as well as sub-lethal developmental effects. For these reasons data from the ZFET serves as a pragmatic starting point to exploring how HTS data may inform ecological risk assessment (ERA). The objective was to determine the reliability and relevance of the ZFET used in the Tox21 program for application to ERA. To assess reliability, both ZFET protocols were analyzed and evaluated by comparing them to the internationally standardized protocol OECD 236: Fish Embryo Acute Toxicity (FET) test. To assess relevance, firstly, each sub-lethal developmental effect measured in the ZFET was gathered for 102 chemicals to determine whether a broad correlation with high chronic toxicity for growth and reproduction exists. Secondly, acute-to-chronic ratios (ACR) were calculated using the ZFET AC 10 results and compared to ACRs based on traditional tests. The combined set of results were used to indicate whether the ZFET assays provide improved predictions of chronic fish toxicity, when compared to traditional acute assays. While the ZFET protocols are broadly similar to the OECD 236, they diverge in key parameters (such as dechorination state, percent mortality in controls, life stage and sample size) that raise questions as to the reliability of the protocols in ERA. Preliminary results indicate that none of the sub-lethal developmental effects were consistently associated with high chronic toxicity and that there is a need to evaluate chronic adverse outcomes on a case-bycase basis. In addition, no clear pattern emerged to indicate that the ZFET data are better predictors when compared to traditional acute data. The current study suggests that the ZFET on its own cannot be extrapolated and applied in a consistent manner to ERA. However, the ZFET can be considered as a potential information source for assessment and can play a key role in a weight of evidence approach in regulatory decision making. Manufacturers of formulated consumer products, such as cosmetics, personal care products, and cleaning products, typically have a chemical portfolio consisting of hundreds and possibly thousands of ingredients used in production. Moreover, many larger consumer product companies have extensive markets that span multiple countries and regions. To manage large chemical portfolios, consumer product manufacturers must understand potential environmental impacts from "down-the-drain" disposal of their products under a variety of conditions. To this end, we evaluated a portfolio of more than 400 "down-the-drain" chemicals used in formulated consumer products sold worldwide. Annual individual ingredient use volumes spanned six orders of magnitude from pounds to millions of pounds, which suggested that an exposure-based approach to prioritization of hazard data development and environmental risk assessment would be resource efficient. Predicated environmental concentrations were estimated using a tiered approach, starting with a simple, conservative "box" model in which 100% of market ingredient volume was assumed to be discharged from wastewater treatment plants. A second-tier evaluation incorporated estimates of chemical removal via wastewater treatment as well as fate and transport modeling of the chemical. This presentation will describe the methodology and automation processes used for a tiered exposure screening to support chemical portfolio management by consumer product companies.
MP014
MP015 High-Throughput In Vitro to In Vivo Extrapolation Workflow to Address Critical Data Needs for Interpreting In Vitro Toxicity Data in Risk Assessment
M. Moreau, ScitoVation / Biokinetics and Biosimulations; M.B. Phillips, M. Smeltz, D. Gullick, R. Norini, L. Burkey, M. Yoon, ScitoVation
In vitro to in vivo extrapolation (IVIVE) methods comprise a family of approaches used to extrapolate from test concentrations used in in vitro assays to external exposures, which are more familiar to regulators, risk assessors, and risk managers. IVIVE methods require knowledge of the absorption, distribution, metabolism, and excretion (ADME) characteristics of a compound. In silico tools are available to predict these characteristics using only the chemical structure of the compound of interest. Structure-based read across methods and QSAR analyses can also be used to fill data gaps. Of the various ADME properties, metabolism is by far the hardest to predict in the absence of experimental data. This often becomes the major source of uncertainty when performing IVIVE for an untested chemical; without this data, it is challenging to properly place in vitro test results in a risk assessment context. We have developed a new workflow for filling data gaps when performing IVIVE for chemicals where ADME data are sparse. Our method incorporates literature data, read across, and QSAR approaches; in silico predictive tools; and a rapid in vitro method for estimating intrinsic hepatic clearance (CLint). To demonstrate our approach, we have taken four chemicals through the proposed workflow: coumarin, propylparaben, tamoxifen, and corticosterone. We also measured CLint for coumarin and propylparaben using a validated analytical method for comparison to the rapid in vitro method. We compare results from different approaches, and discuss strengths and limitations of the currently available methods as well as make recommendations for a path forward. Developing well-accepted and more efficient IVIVE methods will be crucial for the proper interpretation of in vitro hazard data for health risk assessment. Xenobiotic biotransformation in vivo (i.e., "metabolism") can lead to the production of new substances (i.e., metabolites) that are more or less toxic than the parent compound, or that act through a different mechanism. Metabolically competent models generate mixtures of parent and metabolite(s); traditional in vivo models are metabolically competent, facilitating holistic interpretation of the results of external exposure to the toxicant of interest and internal exposure to the biologically relevant mixture of metabolites. One barrier to the widespread acceptance of in vitro toxicity testing as a replacement to animal studies, especially among the regulatory community, is that that many in vitro toxicity models lack metabolic competence. The first step toward understanding the role that metabolism plays in activation/detoxification of chemical substances is to identify the structures of the major metabolites (MetID). Identification of these structures enables researchers to apply in silico predictive tools, perform read across and QSAR, and to prioritize metabolites for further study, either in vitro or in vivo. We have developed a workflow for the rapid identification of metabolites using a combination of in silico predictive tools (MetaSense, ACD/Labs and OECD QSAR Toolbox, OECD) and in vitro experiments using primary hepatocytes, with analysis by liquid chromatography coupled to quadrupole time-of-flight (LC/QTOF) tandem mass spectrometry. To demonstrate our approach, we have taken three chemicals through the proposed workflow: carbaryl, methylparaben, and acetaminophen. We compare results from the published literature, the two in silico tools, and the in vitro incubations, and discuss strengths and limitations of the currently available methods as well as make recommendations for a path forward. Developing well-accepted MetID methods will be crucial for the proper interpretation of in vitro hazard data for risk assessment.
MP017 Prediction of Composition and Emission Characteristics of Articles in Support of Exposure Assessment
C. Addington, Oak Ridge Institute for Science and Education; K. Phillips, USEPA ; K.K. Isaacs, USEPA / National Exposure Research Laboratory
The risk to humans from chemicals in consumer products is dependent on both hazard and exposure. The prediction and quantification of chemical exposure from household articles such as furniture and building materials is an ongoing effort. As opposed to, for example, cosmetic formulations which are regulated by the FDA, the chemical composition of articles are less clear, as are the resulting chemical emission characteristics and exposures. We have developed a modeling methodology to predict the weight fraction of chemicals in a polymeric substrate and corresponding emission characteristics based on chemical and substrate structure. We constructed a database of reported and measured chemical concentrations in articles from publicly available sources including Health Product Declarations (HPDs). This database was then used to train a random forest algorithm which predicts a chemical weight fraction bin based on chemical structure and properties. From the predicted weight fractions and chemical properties, we applied a group contribution method, UNIversal quasi-chemical Functional-group Activity Coefficients-Free Volume (UNIFAC-FV), to approximate steady-state gas phase concentrations (y0) at the substrate surface. The model was compared to published experimental y0 data from chamber experiments. The resulting estimates of y0 can be used to parameterize existing high-throughput exposure models for substrate-chemicals combinations found in consumer articles. Thus from only the "first-principles" of chemical and substrate molecular structure, we can generate an estimate of chemical exposure, which carries information quantifying risk. This abstract does not reflect USEPA policy.
MP018 Analytical Method Development for Organic Pollutants with HPLC and GC-MS
O.O. Asagade, The Federal Polytechnic Ede / Computer Science
Heavy metals in vegetables grown on contaminated soils -It is a common opinion that the oral intake of contaminated vegetables into the body is a major route of human exposure to heavy metals. We carried out a study to evaluate the human health risk associated with consumption of leafy tropical vegetables grown on contaminated soils by considering the transfer factor from soil to vegetables. Vegetable sample were acid digested using microwave assisted digestion system and quantification of the heavy metals (As, Cd, Cr, Cu, Mn, Ni, Pb and Zn) was with the ICP-MS. The result obtained revealed that the levels of metals in most vegetables sample exceeded the maximum tolerable limits established by FAO/WHO for edible plants. The soil samples were from contaminated Lagos including Mushin bus-stop, Ladipo market, the UnilagFaculty of science dumpsite, car and repair pack., etc and the vegetables planted included okro, Ugwu, Soko and Tete. The experiments were carried out at the university's green house under the supervision of gardeners and botanists. The results of these studies showed that though the soils were heavily contaminated with heavy metals and the levels found in vegetables after planting were higher than the Food and Agricultural Organisation (FAO) limits, the bioavailable level found in the vegetables after subjecting them to in vitro extraction were very low. We can therefore confidently say that we are not at risk from consuming vegetables grown on such soils.
MP019 Interactions Between Chemical and Non-Chemical Stressors and Inherent Characteristics Elucidate Children's Mental Health Disparities
F. Nilsen, USEPA / ORISE / National Exposure Research Lab; N.S. Tulve, USEPA / Office of Research and Development, National Exposure Research Laboratory
Children may be more vulnerable to the combined interactions of chemical and non-chemical stressors from their built, natural, and social environments when compared to adults. When children are exposed to cigarette smoke, bisphenol A (BPA), or organophosphate pesticides, they are more likely to be diagnosed with a behavior disorder such as attention deficit hyperactivity disorder (ADHD) or antisocial personality disorder (ASPD). These chemicals affect monoamine oxidase A (MAOA), an enzyme that controls serotonin metabolism. Our objective is to elucidate the links between chemical and non-chemical stressors, inherent characteristics, and activities/behaviors on children's mental health outcomes using our multifactorial conceptual framework. To address all factors that may influence children's mental health outcomes, a stateof-the-science literature review is being conducted. Animal toxicology data from previous studies will be used to determine concentrations of relevant chemicals that affect MAOA activity. Reports of genetic, ethnic, and traumatic experiences will also be assessed for their influence on mental health outcomes and MAOA activity. Following the literature review, a meta-analysis of existing human health and toxicology data will determine if these relationships are found in the general population. Preliminary results show that cigarette smoke and common chemicals inhibit MAOA enzymatic activity, but lifestyle (activities/behaviors) and psychosocial (non-chemical) stressors also play a role in mental health outcomes through MAOA. The two genotypes of MAOA dictate inherent serotonin metabolism. When the low-activity genotype (MAOA-L) is combined with traumatic early life experiences, the outcome is increased aggression, violent tendencies, and ASPD. Gestational alcohol, cigarette, and BPA exposure are also linked to aggression, ADHD, and other mental disorders, potentially through MAOA inhibition. The relationship between chemical exposures, genotype (inherent characteristics), and non-chemical stressors and similar outcomes suggest that mental illness in children may be caused by multiple interacting factors. This work is significant since as many as 20% of children are diagnosed with a mental illness annually in the United States with a large number not receiving adequate treatment. A greater understanding of inherent vulnerability and the onset of mental illness may provide better intervention and treatment options to children in need. Pharmaceutical pollution of surface waters is increasingly recognized as a global problem, but to date, there have been no detailed studies from most African countries. The occurrence of 37 pharmaceuticals belonging to 19 therapeutic classes was studied in surface water, and effluent in Lagos State, Southwest Nigeria. Samples were collected year-round from 22 sites and 27 compounds were detected at least once, many at extremely high concentrations. Maximum concentrations for a range of compounds, including trimethoprim, sulfamethoxazole, cimetidine, atenolol, and paracetamol were in the order of ³150 mg L − 1 . Mean concentrations were in the order of tens mgL − 1 . These values are several orders of magnitude higher than most studies of pharmaceutical occurrence but similar to some other peak concentrations measured in developing countries such as China and India. All sites monitored experienced several pharmaceutical; pollution and there were few clear spatial patterns indicating that a variety of sources exist throughout the catchment, including pharmaceutical manufacturing facilities, STPs, and urban areas where sewage treatment is not provided. The highest mean concentrations occurred for most pharmaceuticals in SS2, SS3, SS5 and SS10. Seasonal variations in concentrations were observed for certain pharmaceuticals, which may be related to the environmental conditions that influence their degradation and seasonal usage or discharge. Pharmaceuticals are indispensable in human lives, although, their usage and discharge into the aquatic environment could lead to ecological problems and antibiotic resistance. Africa governments need to enact policies to clean up sewage discharges to rivers urgently. Increased customer and regulatory demand for sustainable products has placed a renewed importance on developing novel biodegradable chemicals. The ability to rapidly and efficiently screen these new chemicals for biodegradable potential is critical. Current screening tools are useful, but offer challenges such as availability of adequate test equipment, potentially lengthy turnaround times, a high per-sample cost, and a relatively large quantity of test materials required. Thus, there is a need to explore a high-throughput approach for screening biodegradability using commercially available micro-respirometry technology. This poster will provide an overview of one approach to high-throughput screening for biodegradability. The standardized OCED 301F biodegradation screening guideline test was capable of being scaled down for use with the micro-respirometry with minimal modifications. Equivalency was demonstrated between the conventional, full-size method and the miniaturized high-throughput method. Intra-and inter-variability of the high-throughput method were within the variability observed in the conventional method. Reductions in waste, set-up time, and overall cost also were demonstrated. Current challenges and areas of further optimization also will be discussed. There is a need to prioritize thousands of environmental chemicals for further testing with the help of current computational technologies. Here we present a case study on applying a risk-based approach to chemical prioritization based on an initial triage by ranking the ratios between ExpoCast high-throughput exposure estimates and Thresholds of Toxicological Concern (TTCs). In order to first demonstrate the utility of TTCs for triage of environmentally relevant compounds, the following process was applied to 358 ToxCast compounds: 1) oral equivalent doses (OEDs) were calculated based on ToxCast bioactivity measurements and available metabolism data for estimating in vivo clearance, 2) TTC values were determined using the Cramer classification system, 3) OEDs and TTCs were then compared with available ExpoCast exposure estimates to determine their respective activity:exposure ratios. TTCs were lower than OEDs for 349 (97%) of ToxCast compounds, implying that TTCs can serve as a conservative estimate of hazard in the absence of chemical-specific data. A similar triage process was applied to a set of 45,000 chemicals whereby ratios between their ExpoCast exposure estimates and TTC values were evaluated. In order to ground-truth the results, we curated an ensemble of compounds with established points of departure (e.g., no observed adverse effect levels (NOAELs)). TTC values were lower than NOAELs for all 128 compounds that overlap with the chemical database and have published NOAEL values based on a daily oral exposure. This study demonstrated the utility of exploiting existing computational approaches as part of a tiered risk-based approach to prioritize thousands of chemicals for further analysis. This abstract does not necessarily reflect USEPA policy. The VM7Luc4E2 estrogen receptor (ER) transactivation assay is an OECD approved method (TG 457) for the detection of ER agonists and antagonists, and is also part of the Tox21 high-throughput screening (HTS) portfolio. Despite international acceptance as a screening assay, immortalized cell lines such as VM7Luc4E2, which was derived from the MCF7 human breast cancer cell line, do not express a full complement of xenobiotic metabolizing enzymes. This has led to calls for improved methods for the incorporation of metabolic competence into in vitro assays, particularly those used in the detection of endocrine active chemicals. The Alginate Immobilization of Metabolic Enzymes (AIME) platform is an HTS-compatible solution that retrofits existing assays with metabolic competence by attaching alginate-hepatic S9 microspheres to solid supports extending from microplate lids. To determine if the AIME platform could be coupled with the VM7Luc4E2 assay, methoxychlor (MXC) was used as a proof-of-concept reference chemical for bioactivation to a more potent ER agonist. AIME lids were prepared using phenobarbital/β-naphthoflavone-or aroclor-1254 induced rat hepatic S9 as well as heat-inactivated S9 used as a protein binding control. Phenol-red free DMEM/1% FBS supplemented with an NADPH regeneration system was added to 96-well microplates and dosed in 8-point concentration-response with 17β-estradiol (positive control; no metabolism) and MXC. AIME lids were added to the microplates and incubated with the test compounds for 2 hours at 37°C. The AIME lids were removed, the conditioned medium transferred to estrogen-stripped VM7Luc4E2 cells, and further incubated for 24 hours at 37°C prior to measuring luciferase activity. The results demonstrate that the AIME platform produced nearly a 10-fold decrease in the EC50 value of MXC with active S9 microspheres (0.71 µM) compared to the heat-inactivated control (6.8 µM). A similar, albeit smaller, fold change was observed between the EC50 values observed with active S9 microspheres and MXC tested without the AIME lid (4.98 µM) indicating that some MXC may be sequestered by protein binding. Overall, these results demonstrate the potential utility of the AIME platform as a metabolic retrofit for specific HTS assays. This abstract does not necessarily reflect the policy of the USEPA . The prevalence of endocrine disrupting chemicals (EDCs) in the environment is a major public health concern and can lead to developmental defects and cancer. There is an unmet need for high-throughput and robust in vitro assays that can identify EDCs, especially those interfering with estrogen receptor (ER), androgen receptor (AR), and thyroid hormone receptor (THR) (EAT) pathways. Here we introduce a screening approach using a library of 52 compounds to assess and characterize the impact of reference compounds for multiple EDC activities. The method allows for noninvasive, continuous sampling of cellular responses based on impedance measurement of a panel of cells growing on microelectronic sensors embedded in microtiter plates. The impedance signals generate a time-dependent cellular response profile (TCRP) reflecting modulation of signaling pathways impacting cell number, morphology, and attachment. The cell types in the panel display differential sensitivities and unique time-dependent cell response profiles (TCRPs) toward different EAT receptors agonists. Due to the multiparametric nature of the TCRP approach, multiple EAT modulating activities in addition to cytotoxicity was detected in a single assay. Results demonstrate that EAT modulators were identified in this screen with high sensitivity. Of significance, 6 compounds with AR antagonist activity were confirmed for the first time in an in vitro assay, supporting observed in vivo effects. All 7 known THR agonists in the library were identified by the TCRP assay, including four new compounds (simazine, atrazine, prochloraz, bisphenol F) which have only been identified previously by in vivo tests. For ER modulators, the cell panel-based TCRP method showed high specificity, as all ER modulators identified in this cell panel assay were previously identified with the same activities. In addition, three strong ER antagonists were identified by the TCRP approach, while six additional compounds were reported to be weak ER antagonists by in vivo studies or reporter assays, but not in the TCRP method. Overall, compounds not previously identified in vivo were reported as negative in this screen, suggesting that the method is highly specific. The results suggest that the TCRP method in combination with EAT-responsive cell panel is specific and sensitive to identify and differentiate endocrine disruptors targeting EAT receptors, with high correlation to in vivo data. Thyroid hormone (TH) homeostasis is dependent on multiple proteins for TH synthesis, transport, and peripheral metabolism and elimination. Deiodinase enzymes play an essential role in converting THs between active and inactive forms by deiodinating the pro-hormone thyroxine (T4) to the active hormone triiodothyronine (T3) and modifying both T4 and T3 to inactive forms. Chemical inhibition of deiodinase activity has been identified as an important endpoint to include in screening chemicals for thyroid hormone disruption. To address the lack of data regarding the potential of chemicals to inhibit the deiodinase enzymes, we developed robust 96-well in vitro assays for screening chemicals for inhibition of human deiodinase types 1, 2, and 3 enzyme activity using a nonradioactive detection method. With these assays, we screened over 1800 unique chemicals from the USEPA's ToxCast phase 1_v2, phase 2, and e1k libraries to identify those that have the potential to disrupt the thyroid axis via deiodinase inhibition. The majority of the chemicals did not inhibit deiodinase activity in the initial screen with a single high concentration (target concentration of 200 µM). There were 411 chemicals that produced enzyme inhibition of 20% or greater in at least one of the three deiodinase assays. Of these, 228 chemicals produced enzyme inhibition of 50% or greater; these chemicals were further tested in concentration-response mode to determine relative potency. The chemicals identified as 'active' were from all three chemical libraries and a range of chemical types (e.g., pesticides, industrial products, food additives, pharmaceuticals). Comparison across the three deiodinase isoforms shows similar results for over 90% of the tested chemicals; however, there are over 50 chemicals that show greater than 50% inhibition of only one of the three deiodinases. This set of three deiodinase inhibition assays is a significant contribution to the effort towards expanding the limited number of in vitro assays used to identify chemicals having the potential to interfere with thyroid hormone homeostasis. Additionally, this study sets the groundwork for development and evaluation of structure-activity relationships for deiodinase inhibition, and informs targeted selection of chemicals for further testing to identify adverse outcomes of deiodinase inhibition.
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MP021 Application of Micro-Respirometry in
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TP003 Screening the ToxCast Phase 1, 2, and e1k Chemical Libraries for Inhibition of Deiodinase Types 1, 2 and 3 Enzyme Activity
TP004 Tackling Compound Polypharmacology by Transcription Factor Activity Profiling
Evaluation of biological activities of compounds has been greatly advanced by transcriptomics. However, gene signatures provide only indirect information about the underlying biological phenomena. Here, we present an alternative approach, wherein cell response is characterized by changes in the network of signal transduction pathways that regulate gene expression. Using a multiplexed reporter assay, we assessed the activity of transcription factors that lie at the apexes of these pathways, thereby generating a quantitative signature (TF activity profile (TFAP)). We show that perturbations of different cell systems and biological pathways in human cells produce distinct TFAPs. Strikingly, perturbagens of a given system, regardless of structural and mechanistic dissimilarities, have produced an invariant TFAP, representing an "archetypal signature" of bioactivity. We found archetypal signatures for multiple bioactivities, including mitochondrial, HDAC, and ubiquitin/proteasome pathway inhibitors; cytoskeleton disruptors; and DNA-damaging agents. These TFAPs enabled correct identification of compounds with given bioactivity among uncharacterized chemicals. Furthermore, we show that observing changes of a compound's TFAP with concentration enables the identification of multiple target systems and reveals the on-target and off-target activities of drugs. Thus, TFAPs represent a new kind of descriptors that enable a straightforward, mechanism-based evaluation of compound polypharmacology. Supported by the NIH grant R44GM125469. The views expressed in this presentation are those of the authors and do not necessarily reflect the views or policies of the USEPA . Mention of trade names does not constitute an endorsement by the USEPA . Large-scale screening facilities utilize 1,536 well plates and select assays amenable to this microwell plate format. However, conducting assays in 1,536 well plates requires special instrumentation that is outside the operating budget of many laboratories. Even submitting samples for HTS in these state-of-the-art facilities can be cost-prohibitive. Therefore, many laboratories still utilize the relatively inefficient 96-well plate format even if the assays are capable of performing in higher micro-well plates. We previously developed a method in 384-well plates for testing pure chemicals and mixtures of pure chemicals in two commonly used human breast luciferase transactivation cell bioassays, the estrogen agonist/ antagonist screening VM7Luc4E2 cell bioassay (previously designated BG1Luc4E2) and the androgen/glucocorticoid screening MDA-kb2 cell bioassay. Here, we propose a modification of that method for screening and dilution analysis of environmental samples that would lower sample volume requirements and enhance a smaller-scale laboratory's sample throughput by 4-fold (in comparison to 96-well plates) without additional cost. We successfully tested various food (fish feed) and environmental extracts (sediment and water) for agonist and antagonist activity in the VM7Luc4E2 cell line and in the VM7LucERbc9 cell bioassay (previously designated BG1LucERbc9), which is the VM7Luc4E2 cell line stably modified to express estrogen receptor beta (ERb) . From dilution analysis, we obtained sample estradiol equivalents (EEQ), with sensitivity to yield EEQ values as low as 20 pg E2/L water or /g sediment and were able to compare the impact of ERb expression on sample activity and EEQ values. Assay performance in the VM7Luc4E2 and VM7LucERbc9 cells, respectively, was as follows: minimal detection limit was 0.68-2.1 fg E2/ well (in both cell lines); half-maximal activity (EC 50 ) achieved with 31 ± 7.9 and 38 ± 8.1 fg E2/well; assay response coefficient of variation (CV) 6.1 ± 3.1% and 6.1 ± 1.9%; Z? factors 0.81 ± 0.11 and 0.77 ± 0.13; signal to background (S/B) ratios 115 ± 49 and 74 ± 28; and limits of quantification (LOQ)/limits of detection (LOD) 1.5 ± 0.95%/0.52 ± 0.32% and 2.9 ± 2.3%/0.91 ± 0.76% (LOQ/LOD expressed as a percent of maximum E2 response). This method also included the two part luciferase/ fluorescamine assay which we found useful in distinguishing possible cytotoxicity from antagonism induced by sample treatment. In vitro based assays are increasingly being used to identify potential endocrine disrupting chemicals. Thyroperoxidase (TPO), an enzyme essential for thyroid hormone (TH) synthesis, is a target site for disruption of the thyroid axis for which a high-throughput screening (HTPS) assay has recently been developed. Physiologically based pharmacokinetic / pharmacodynamic (PBPK/PD) models can aid in translating findings from in vitro assays to in vivo effects. This study used known TPO inhibitors, methimazole (MMI) and 6-propylthiouracil (PTU), to provide in vivo data for PBPK/PD modeling. Adult male LE rats were exposed to 0, 1, 3, and 10 ppm PTU or 0, 3, 30 or 200 ppm MMI in drinking water for 4, 7, and 14 days. Serum and thyroid glands were collected to assess PTU, MMI, and TH levels. Serum and gland PTU and MMI levels increased in a dose-dependent manner. Serum T3 and T4 were reduced by PTU in a dose-and time-dependent manner, with larger decrements seen at all time-points with exposure to 3 and 10 ppm. TSH was elevated after 7 days of exposure, largest increases observed with 14-day exposure to 10 ppm PTU. However, the low dose group did not differ from controls, despite declines in serum T3 and T4. Serum T3 and T4 decreased with 4-day exposure to MMI. TSH increased with 7 and 14-day exposure to 30 and 200 ppm MMI. T3, T4, rT3, and mono-and di-iodotyrosines (MIT, DIT) were also measured in the glands of rats exposed to PTU for 4 days. TH levels decreased in a dose-dependent manner with greatest decreases observed in DIT (53%, 73%) and T4 (40%, 80%) following exposure to 1 and 10 ppm PTU, respectively. Glandular TH and PTU measures permitted the estimation of in vivo TPO inhibition using a PBPK/PD model. The in vivo derived inhibition constant (IC 50 ) for TPO was 1.55 µM which was slightly higher than the in vitro IC 50 value of 1.24 µM. Analyses of additional time-points are underway for gland concentrations of chemical and TH as well as ex vivo measures of TPO inhibition using Amplex UltraRed assay in the glands of exposed animals. These data provide a framework to translate the magnitude of TPO inhibition obtained from HTPS assay relative to the degree of TH perturbation in vivo. Does not necessarily reflect USEPA policy. Exposure to endocrine disrupting chemicals have been associated with compromised testosterone production leading to abnormal male reproductive development and altered spermatogenesis. In vitro high throughput screening (HTS) assays are needed to evaluate risk to testosterone production, yet the main steroidogenesis assay currently utilized is a human adrenocortical carcinoma cell line, H295R, which does not synthesize gonadal steroids at the same level as the gonads, thus limiting assay sensitivity. We propose a complementary assay using a highly purified rat Leydig cell assay to evaluate the potential for chemical induced alterations in testosterone production by the testis. We evaluated a subset of chemicals that failed to decrease testosterone production in the HTS H295R assay. The chemicals examined fit into one of two categories based upon changes in substrates upstream of testosterone in the adrenal steroidogenic pathway (17α-hydroxyprogesterone and 11-deoxycorticosterone) that we predicted should have elicited a decrease in testosterone production. We found that 85% of the 20 test chemicals examined inhibited Leydig cell testosterone production in our assay. Importantly, we adopted a 96 well format to increase throughput and efficiency of the Leydig cell assay and identified a selection criterion based upon the AC50 values for 17α-hydroxyprogesterone and 11-deoxycorticosterone generated from the HTS H295R assay that will help prioritize chemicals for further testing in the Leydig cell screen. We hypothesize that the greater dynamic range of testosterone production and sensitivity of the Leydig cell assay permits the detection of small, yet significant, chemical induced changes not detected by the HTS H295R assay. Current efforts include using an in vitro to in vivo extrapolation approach to investigate the in vivo relevancy of significant in vitro concentrations. This abstract does not reflect USEPA policy D.A. Dreier, N.D. Denslow, C.J. Martyniuk, University of Florida / Physiological Sciences High-throughput screening (HTS) has provided toxicity data for an unprecedented number of chemicals. This information, coupled with structural data, can reveal chemical features most likely to be associated with early molecular initiating events (MIEs). Within the adverse outcome pathway (AOP) framework, such information may also be useful to discern the mode of action of a substance when several MIEs are predicted to exist. For example, there are multiple endocrine MIEs (i.e., androgen receptor agonism, estrogen receptor antagonism, aromatase inhibition) leading to impaired synthesis of vitellogenin, an egg-yolk precursor protein necessary for reproduction in fish. However, several alternative modes of action (i.e., mitochondrial dysfunction, oxidative stress, aryl hydrocarbon receptor agonism) can also reduce vitellogenin synthesis. Since these alternative pathways may confound results in fish reproduction assays, it is important to characterize predominant MIEs leading to apical responses for environmental risk assessment. Thus, the objective of this study was to leverage HTS data to identify chemical features leading to unique MIEs for impaired vitellogenesis. First, hit calls were extracted for 8 Tox21 assays describing 6 MIEs leading to impaired vitellogenesis. Substances were then parsed using CSRML for 729 ToxPrint chemotypes, yielding a final dataset with 3679 unique substances. The ToxPrints were then used to build predictive models for each assay using 2 approaches. First, a correlation analysis revealed the "ring:aromatic_benzene" ToxPrint had the strongest correlation with assays describing 4 of the 6 plausible MIEs. Next, a random forest classification model was constructed for each MIE and validated (out-of-bag estimated error rate 2-15%) using the RandomForest package in R. In this analysis, it was found the "ring:hetero_[5]_N_imidazole" ToxPrint was most important for predicting aromatase inhibition and oxidative stress, "ring:fused_steroid_generic_[5_6_6_6]" for androgen receptor agonism, and "ring:aromatic_benzene" for aryl hydrocarbon receptor agonism and mitochondrial dysfunction. Thus, compared to conventional predictive methodologies, these results suggest machine learning may offer a valuable approach to identify novel chemical features (or combinations thereof) associated with toxicity. In context of the AOP framework, this study presents a step forward to enhance the use of HTS for environmental risk assessment. Chemical contamination of our ecosystems is regarded as one of the planet's greatest threats. Regulatory agencies and businesses are tasked with managing these chemicals but face significant challenges due to the sheer number of chemicals for which toxicity data are required. It has become increasingly apparent that current risk assessment strategies that rely heavily on animal testing and are prohibitively time-consuming and expensive are not able to address these regulatory mandates. We have recently been awarded a Large-Scale Applied Research Program (LSARP) grant from Genome Canada to develop, test, validate, and commercialize quantitative PCR-based arrays ("EcoToxChips"; containing 384 prioritized genes) to address an urgent worldwide need for advanced toxicity testing tools that are accessible, affordable, consistent, and reliable. To facilitate their adoption into standard practices we will produce and leverage social science knowledge, as well as provide a user-friendly bioinformatics portal (EcoToxXplorer.ca) and an end-user vetted technical guidance document. The anticipated socioeconomic benefits associated with the adoption of our deliverables, namely more focused animal testing, improved regulatory decision-making, and cost-efficiencies. Here we will provide a broad overview of our project. The roles and responsibilities of government are becoming more complex as the need to balance the demands of domestic citizenry and the global economy increases (Dhliwayo, 2017) . Chemical risk assessment presents a particularly complex public policy challenge, with local to global dimensions, requiring considerable interdisciplinary and inter-sectoral dialog and broadly accepted strategies for validating and integrating new technologies into risk management frameworks (Rowlands et al., 2014) . Toxicogenomics -and alternative testing technologies more generally -have been identified as having the potential to introduce important changes in the regulatory governance of chemical risks to human health and the environment. In North America, these technologies have been discussed for more than a decade as a potential answer to the chemical risk assessment challenges facing regulators. However, the accepted regulatory approaches to managing risk and the associated toolkits for prioritizing chemicals and determining their ecological toxicity has remained, for most part, unaffected. Importantly, incorporating toxicogenomic technologies in the regulatory toolkits of government raises a complex web of interdependencies involving cross-jurisdiction regulatory dialogues, large-scale research collaborations, and innovation in both technological tools and in regulatory science. As a result, core questions related to the potential for government agencies to enhance public value through innovation in domestic chemical risk assessment and regulation remain open. In particular, the barriers to, and opportunities for, regulatory innovation in public chemical risk assessment would benefit from further research to inform public policy options.
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TP007 The Use of Purified Rat Leydig Cells Complements the H295R Screen to Detect Chemical-induced Alterations in Testosterone Production
TP008 What Can Machine Learning with High-Throughput Screening Data Teach Us About Impaired Vitellogenesis in Fish?
TP010 What Role for Toxicogenomics in the Governance
TP011 Performance Evaluation of High-Throughput Transcriptome Extrapolation Techniques
D. Mav, A. Tandon, J. Phillips, D. Phadke, B.E. Howard, R. Shah, Sciome LLC The Tox21 consortium is tasked to identify patterns of chemically-induced biological responses in order to characterize toxicity and disease pathways in a high-throughput manner and prioritize compounds for more extensive toxicological evaluations. The Tox21 is pursuing alternatives to cost prohibitive gene expression assessment techniques (Microarray or RNA-seq) that enable assessment of selected transcriptomic subsets in a high-throughput manner. Subsets measured using those techniques are not readily usable with standard differential pathway detection algorithms like Gene Set Enrichment Analysis (GSEA). This can yield limited genelevel differential expression results, necessitating the extrapolation of unmeasured portions of the transcriptome using inferences from measured portions. This can be achieved by modeling gene to gene interconnectedness of the transcriptome via large curated training samples with available whole transcriptome measurements. We present results of a transcriptome extrapolation comparing two popular large data extrapolation techniques: principal component regression (PCR) and Deep Learning (DL). For PCR, an eigenvalue ratio threshold of 0.1 was applied to identify significant PCs and perform prior standardization of inputs. For DL, a multi-task multi-layer feedforward neural network consisting of one input layer, 3 hidden layers (with 3,000 hidden units each), and one output layer was customized. RMA normalized signal for all unique (N=117,559) GPL570 microarray data files from NCBI Gene Expression Omnibus (GEO) were downloaded and computed. The probe-set signal values were averaged to compute gene-level signal with NCBI's gene information database. The signal from 2,729 NCBI genes was used to extrapolate signal for 18,167 genes using each method. The extrapolation performance of each method was evaluated using 20-fold cross validation. Results indicate that PCR extrapolation outperforms DL extrapolation in terms of root mean square error (RMSE; PCR=0.39 vs. DL=0.51), median absolute error (MAE; PCR=0.20 vs. DL=0.26), and rank-biased overlap between the top 10% of true and extrapolated genes (RBO; PCR=66% vs. DL=58%). Additionally, PCR extrapolation is less computationally intensive, increasing its overall utility. These extrapolation efforts improve the scale and utility of transcriptomic data to fill in gaps between subsets of genes measured in individual studies and the ability to assess the entire transcriptome. High-throughput transcriptomic (HTTr) technologies are increasingly being used to screen environmental chemicals in vitro to provide mechanistic context for regulatory testing. The development of gene expression biomarkers that accurately predict molecular and toxicological effects including cancer and endocrine disruption is needed to accurately interpret HTTr data streams. We have developed strategies to build and test gene expression biomarkers that can assess the modulation of key events in AOPs. Biomarkers were built using microarray profiles from human cells in which the key event (e.g., androgen receptor; AR) was either activated or suppressed by chemical modulators followed by a genetic filter that included only those genes that were also regulated when the factor was overexpressed or knocked down. Using this strategy, we built biomarkers that assess the activity in chemically-treated cells of ~40 transcription factors, signaling pathways, or phenotypes and examine the effects of ~2500 chemicals across multiple cell lines. As one example, AR biomarker genes were identified by their consistent expression after exposure to 4 AR agonists and opposite expression after exposure to 4 AR antagonists. A genetic filter was used to include only those genes that were regulated by modulation of the AR protein. The biomarker was evaluated as a predictive tool using the fold-change rank-based Running Fisher algorithm which compares the expression of AR biomarker genes under various treatment conditions. Using 163 comparisons from cells treated with 98 chemicals, the biomarker gave balanced accuracies for prediction of AR activation or AR suppression of 97% or 98%, respectively. The biomarker was able to correctly classify 16 out of 17 AR reference antagonists including those that are "weak" and "very weak". Predictions from AR-positive LAPC-4 cells treated with 28 chemicals in antagonist mode were compared to those from the ToxCast AR pathway model based on 11 in vitro high-throughput screening assays that queried different steps in AR signaling. The balanced accuracy was 93% for suppression. These results demonstrate that the AR gene expression biomarker could be a useful tool in HTTr to identify AR modulators in large collections of microarray data derived from AR-positive prostate cancer cell lines. This abstract does not represent USEPA policy. EcotoxicologyIn (eco)toxicological research "omics" technologies are increasingly used and supposed to improve chemical regulatory assessments in the future. Several studies have analyzed the transcriptome of the zebrafish embryo after chemical exposure, however, to our knowledge, results of ZFE toxicogenomics studies have not been aggregated or compared so far, which is important to get a better understanding of the so far isolated results. For instance in many studies it could not be clearly resolved, which of the observed effects were specific for the compound studied and which would be expected to be of a more general nature, e.g. related to the embryonic stage or a disturbance of global homeostasis. We suspect compounds to act via a range of different molecular mechanisms (e.g. target molecules), but we also expect effect cascades to converge into smaller and more general sets of toxicity pathways. Thus, we aimed at the identification of genes or gene sets showing a general response towards chemical exposure in a meta-analysis. We compared 33 published microarray studies including exposures of the ZFE to 60 different chemical compounds (948 arrays in total) and aimed at identifying common transcriptional regulation across all experiments as well as across meaningful subgroups. We found that the analyzed transcriptome studies show great heterogeneity in experimental settings which is probably one cause for the also observed heterogeneity in gene regulation. However, in selected experimental subgroups we could identify common trends of gene regulation and connected them to different biological processes. The analysis reveals some methodological constraints of existing ZFE transcriptome studies but it also provides a starting point to substantially increase our understanding about molecular effects and stress responses in the developing ZFE using transcriptome studies.
TP012 Using Gene Expression Biomarkers to Identify Chemicals that Induce Key Events in
TP013 Zebrafish Transcriptomes After Chemical Exposure -A Quest for Common Grounds
TP014 Applicability of the Bioactivity-to-Exposure Ratio (BER) Approach to Ecologically Relevant Species
C. Inglis, J. Prindiville, F. Pagé-Larivière, Environment and Climate Change Canada; A. Nong, Health Canada Advances in toxicity testing have led to a rise in the application of in vitro and high throughput screening (HTS) assays to predict potential adverse effects in risk assessment. However, relying on nominal assay concentrations may under-or over-estimate potential in vivo effects given chemical differences in bioavailability, distribution and clearance. The bioactivity-to-exposure ratio (BER) approach which converts in vitro assay concentrations (i.e., bioactivity) into in vivo internal doses, via in vitro to in vivo extrapolation (IVIVE), and compares these concentrations to exposure predictions to determine the margin of exposure, has recently been considered for use in human health risk assessment (Thomas et al. 2013) . However, the application of the BER approach has not been considered in ecologically relevant species and for ecological risk assessment. The current study has two objectives 1) to apply a mass balance model (Armitage et al. 2014) to address partitioning of chemicals in an in vitro test system and to estimate the cell uptake and concentration resulting from exposure and 2) to apply a reverse toxicokinetic model for fathead minnow (Rowlands et al. 2017 ) to the estimated cell concentration results in order to calculate predicted environmental concentrations (PECs) at which a bioactivity response is expected to occur at steady-state. As part of a case study to develop and validate ecological risk assessment methodology to integrate HTS data, these models and approaches will be applied to a sub-set of ~18 chemicals, for which traditional chronic data and biotransformation rates exist, across ~300 HTS assays, to determine the validity and applicability of the BER approach in ecologically relevant species. The BER results for each of these chemical-assay pairs will help develop tools and supporting data to prioritize and assess chemicals in an ecological risk assessment context. Chemical pollution is an increasing threat to our environment. Conventional chemical monitoring programs have been criticized on the basis that they cannot include the full range of chemical pollutants that could occur in the environment including transformation products, and they do not account for the combined effects of mixtures of chemicals. Bioanalytical tools may therefore complement chemical analysis for cost-efficient monitoring. Bioanalytical tools are cell-based bioassays that target specific mechanisms of toxicity and give a measure of the toxicity of mixtures of known and unknown chemicals, such as pesticides, industrial chemicals, pharmaceuticals and their transformation products. They provide measures of the cumulative effects of chemicals that exhibit the same mode of toxic action, for which the selected bioassays are indicative plus they can give a measure of the cytotoxicity of all chemicals acting together in an environmental sample. Bioanalytical tools have been applied for water quality monitoring of sewage, wastewater treatment processes, advanced water treatment and drinking water and also for surface water quality monitoring. Here we present the water quality evaluation of a small river impacted predominantly by two wastewater treatment plants on the catchment scale using chemical analysis of pharmaceuticals and pesticides combined with seven reporter gene assays covering endocrine effects, activation of metabolic enzymes and oxidative stress response. While the larger wastewater treatment plant had substantial influence on the overall burden of chemicals and biological effects, the tributaries carried a smaller load of chemicals, albeit with different profiles of modes of action. Comparison of the results with tentative effect based trigger values demonstrated that small creeks with a low flow rate of receiving water can be quite impacted by treated wastewater exceeding safe levels of effects.
TP015 Bioanalytical Tools Complement Chemical Analysis to
For understanding the mixture effects of organic micropollutants in water quality monitoring, the matrix of natural organic matter, inorganics and metals needs to be removed prior to testing in HTS bioassays. In addition, these mixture needs to be enriched to quantify effects in relatively clean water samples such as surface water and drinking water and to avoid any matrix artefacts in more polluted samples such as landfill leachates, stormwater or wastewater. Solid-phase extraction (SPE) is commonly applied for sample enrichment prior to bioanalysis of water samples. While the recovery of individual chemicals by SPE has been well studied and SPE methods have been optimised for maximum chemical recovery, very little is known about effect recovery for bioassays. The current study applied a new approach to experimentally determine effect recovery for bioassays. A pristine water sample was spiked with a mixture of 579 micropollutants and extracted using large volume solid-phase extraction (LVSPE). The spiked and unspiked LVSPE water extracts, as well as the chemical mixture, were measured in a suite of bioassays covering different stages of the cellular toxicity pathway, including activation of xenobiotic metabolism, hormone receptor-mediated effects and adaptive stress responses. For the majority of assays, effect recovery was within a factor of two of the expected 100% recovery and was similar to recovery by chemical analysis for LVSPE. In addition to high recovery, low blank effects are required for bioanalysis, so blank effects were evaluated in LVSPE and another SPE method used for water quality monitoring, multi-layer SPE. While multi-layer SPE has greater chemical recovery, cytotoxicity was observed in the blanks at high enrichment, while no effects were observed in the LVSPE blanks. Finally, reverse recovery modelling using chemical recovery data for LVSPE and multi-layer SPE was retrospectively applied to published water quality monitoring case studies to estimate the loss of effect by SPE. In the majority of cases, there was no substantial loss of effect by SPE. Overall, this study indicates that SPE is a suitable sample preparation method for environmental water samples, with effect recovery by current SPE methods similar to recovery by chemical analysis. Surface-water contaminant mixtures and associated aquatic-health effects are growing concerns. Replicate (n = 3-10) water samples were collected from 54 small Piedmont (USA) streams over 10 weeks and analyzed for 489 organic analytes (470 unique chemicals), including 110 pharmaceuticals and degradates, 226 pesticides and degradates, 84 volatile organic chemicals, and 69 organic waste indicator compounds. Of these, more than 200 were detected at least once across all sites and more than half of the detected water contaminants were designed-bioactive organic chemicals (e.g., pharmaceuticals, pesticides). Cumulative detections and concentrations ranged up to more than 150 compounds and 100 µg L-1 respectively. Due to multiple modes of action, high bioactivity, biorecalcitrance, and direct environment application (pesticides), the frequent detection of designed-bioactive organics at cumulative concentrations up to μg L-1 raise concerns for sub-lethal effects to sensitive aquatic species and lifecycle stages. Predicted cumulative effects of the chemical exposures observed in this study were estimated for a range of molecular endpoints using cumulative Exposure Activity Ratios (∑EAR) based on high-throughput screening data in ToxCast. Ecotoxicology In the environment, chemicals occur in complex mixtures rather than individual entities. Hence, environmental quality monitoring faces the challenge to comprehensively assess a multitude of contaminants and potential adverse effects. To meet this challenge, effect-based methods have been suggested as complements to analytical characterization of complex pollution patterns. Here, we present an interlaboratory study which investigates the suitability of effect-based bioassays for mixture effect elucidation by conducting the toxicological potential of individual, high priority pollutants and their mixtures with a panel of effect-based bioassays. The tested compounds were of diverse chemical structure and unique known mode of action (MoA). The bioassay panel consisted of whole organism assays measuring apical effects and cell-based bioassays with more specific effect observations. After single substance dose-response determination, bioactive substances were selected and two mixtures modeled. One mixture contained at least two active components for each bioassay that was able to detect single substance toxicity, thus allowing mixture effect elucidation within the bioassay panel to the greatest possible extent. A second mixture consisted of the same components but in environmentally relevant concentrations, thus aiming at reflecting naturally occurring circumstances and illustrating the impact of low-concentrated chemical mixtures on various organisms. Hence, observed mixture effects were compared against two mixture effect prediction models derived from additivity expectations, the model of concentration addition (CA) and independent action (IA). Most of the assays detected the mixture response of the active components as predicted even against a background of inactive contaminants. When none of the mixture components showed any activity by themselves then the mixture was also without effects. With one exception, the mixture effects observed using apical endpoints mainly appeared within the prediction window set by both applied models, whereas the specific celland organism-based endpoints resulted in mixture responses according to the model of CA. Concluding, most effect-based bioassays were able to quantitatively detect the predicted mixture effects, thus illustrating the importance of including mixture toxicity evaluation in risk assessment and further supporting the idea of combining chemical with bioanalytical monitoring tools. Improper management of abattoir activities in the Kara Cow Market, Ogun State, Nigeria, poses adverse effects on the health of the Ogun river, which would ultimately affect humans if left unattended. In this study, the physico-chemical characteristics of the abattoir wastewater were evaluated. The ninety-six hour median lethal concentration of the wastewater against fingerlings of Clarias gariepinus was determined. Furthermore, the biochemical and histological effects of sublet half concentration of the wastewater on C.gariepinus over a period of twenty-eight days were investigated. All studies were conducted following standard methods. The results of the physico-chemical analysis showed that most parameters exceeded set limits by the World Health Organization. The median lethal concentration of the wastewater after 96 hours was 126 ml/L. The wastewater had no significant effect on C.gariepinus during the sublethal toxicity study as the biochemical and histological biomarkers appeared normal after 28 days of exposure to the abattoir wastewater. In conclusion, the results of the physico-chemical analysis showed that the wastewater is a potential risks to the environment. However, further studies need to be conducted so as to full comprehend the severity of the wastewater on living organism.
TP017 Mixed Contaminant Exposure and Predicted Effects in
TP018 Suitability of Effect-based Bioassays for Mixture Effect Elucidation
TP019 Evaluation of the
TP020 High-Throughput Tools for Environmental Monitoring Based on Transcriptome Sequencing and Biomarker Assay for the Indigeneous Clam Moerella iridescens
Z. Wang, Key Laboratory of Urban Environment and Health
Indigenous clam, Moerella iridescens is one of the major aquaculture species in China and a potential sentinel organism for monitoring the status of coastal ecosystems. However, the molecular mechanisms underlying absorption and digestion in M. iridescens are not well understood due to the lack of available genomic information for this species, particularly for internal genes specifically related to environmental stress. In the present study, the transcriptomes of M. iridescens collected from polluted lagoon and clean area were characterized using the Illumina next-generation sequencing technique, producing over 230 million high-quality reads, and a global de novo assembly generated a total of 90282 contigs and 86877 transcripts (unigenes), of which 18,727 (21.6%) had significant similarities to proteins in the Uniprot database. In addition, 285,872 annotated sequences were associated with Gene Ontology (GO) terms. A kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment was performed for the unique unigenes, and 317 pathways (p-value< 10-5) in M. iridescens were found to be predominantly related to contaminant absorption and digestion, especially that several important genes are associated with key biological processes, such as defense against either oxidative stress or tissue/protein damage, detoxification, and vitellogeninlike proteins. The qRT-PCR results confirmed that the expression patterns of these genes were consistent with the RNA-Seq results, suggesting an adaptive strategy for this species in the deeply impacted environment. In total, this study represents a first attempt to characterize M. iridescens transcriptome sequencing and consequent annotation, which will increase the available tools and resources for this species. Summarizing, despite the known limitations in transcript annotation and sequence coverage for non-model species, sufficient information was obtained to identify a large set of differentially expressed genes potentially involved in biological process and cellular response to environmental stress, indicating that the possibility of high throughput experiments such as RNA-seq paves a very promising way to define multiple indicators of the health status of sentinel organisms for environmental hazard assessment. The volume and variety of manufactured chemicals is increasing, though little is known about the risks associated with the frequency and extent of human exposure to most chemicals. The USEPA and the recent signing of the Lautenberg Act have both signaled the need for high-throughput methods to characterize and screen chemicals based on exposure potential, such that more comprehensive toxicity research can be informed. Prior work of Mitchell et al. using multi-criteria decision analysis tools to prioritize chemicals for further research is enhanced here, resulting in a high-level chemical prioritization tool for risk-based screening. Reliable exposure information is a key gap in currently available engineering analytics to support predictive ecological and human health risk assessments. An elicitation with 32 experts informed relative prioritization of risks from chemical properties and human use factors, and the values for each chemical associated with each metric were approximated with data from USEPA's CP_CAT database. Three different versions of the model were evaluated using distinct weight profiles, resulting in three different ranked chemical prioritizations with only a small degree of variation across weight profiles. Future work will aim to include greater input from human factors experts, better define qualitative metrics, and identify opportunities to extend to ecological exposure applications. 
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